Compounds > ticlopidine
Page last updated: 2024-11-05

ticlopidine and Postoperative Complications

ticlopidine has been researched along with Postoperative Complications in 313 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Research Excerpts

ExcerptRelevanceReference
"This study aimed to compare preoperative treatment using clopidogrel and ticagrelor for patients with acute myocardial infarction (AMI) undergoing emergent percutaneous coronary intervention (PCI), and to investigate the efficacy and safety of these medications in the management of AMI."9.20Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Zhang, N; Zhang, Q; Zhu, K, 2015)
"There were two episodes of thromboembolism in the ticlopidine group at 1 month and 6 months respectively, with a linearized incidence of 0."9.08Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. ( Agredo, J; Aramendi, JL; Larrarte, C; Llorente, A; Pijoan, J, 1998)
"It is unknown whether pretreatment with clopidogrel in acute coronary syndrome (ACS) managed invasively, is superior to a strategy of administering clopidogrel in the cardiac catheterization laboratory at the time of percutaneous coronary intervention (PCI)."8.95Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. ( Mukherjee, D; Naidu, SS; Nairooz, R; Pothineni, NV; Raina, S; Rochlani, Y; Sardar, P; Shavelle, DM; Valgimigli, M, 2017)
"Variable response to clopidogrel can impact perioperative risk in elective endovascular intracranial aneurysm treatment."7.85Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response. ( Delgado Almandoz, JE; Fease, JL; Kayan, Y; Milner, AM; Mulder, M; Scholz, JM, 2017)
"There is a known bleeding risk with administration of the antiplatelet drug clopidogrel, but in certain patients the likelihood of thrombosis is too high to cease its administration perioperatively."7.81Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series. ( Bono, J; Nandi, S; Shubert, D, 2015)
"Although randomized clinical trials have compared clopidogrel with higher potency ADP receptor inhibitors (ADPris) among patients with myocardial infarction, little is known about the frequency and factors associated with switching between ADPris in clinical practice."7.80In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. ( Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y, 2014)
"The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown."7.80Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014)
" We aimed to determine the relationship between high on-treatment platelet reactivity (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel."7.78Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. ( Armero, S; Barragan, P; Berbis, J; Bessereau, J; Bonello, C; Bonello, L; Camillieri, E; Camoin-Jau, L; Dignat-George, F; Jacquin, L; Laine, M; Paganelli, F, 2012)
"To identify factors related to thromboembolic events during coil embolization for unruptured intracranial aneurysms and to evaluate the role of clopidogrel premedication to prevent thromboembolisms."7.76Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? ( Han, MH; Jung, C; Kang, HS; Kim, JE; Kwon, BJ; Kwon, OK; Oh, CW, 2010)
" The objective of this study is to assess the relationship between response to clopidogrel and post-treatment platelet reactivity (PPR) and 1-year major adverse cardiovascular events (MACE) in patients with non-ST segment elevation acute coronary syndrome (NSTEACS)."7.75Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. ( Alonso Orcajo, N; Alonso Rodríguez, D; Carbonell de Blas, R; Cuellas Ramón, C; de Miguel Castro, A; Diego Nieto, A; Fernández Vázquez, F; Pascual Vicente, C; Pérez de Prado, A; Samaniego Lampón, B, 2009)
"The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt."7.73Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005)
" Combined major adverse cardiovascular event (stroke, MI, and death) was not different in the two groups (OR 1."6.47Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. ( Athanasiou, T; Malik, IS; Nijjer, SS; Watson, G, 2011)
"Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis."6.15Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986)
" However, it is unclear whether antiplatelet monotherapy with ticagrelor alone versus ticagrelor plus aspirin reduces the incidence of clinically relevant bleeding without increasing the risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in ACS patients undergoing percutaneous coronary intervention (PCI) with DES implantation guided by either intravascular ultrasound (IVUS) or angiography who have completed a 1-month course of DAPT with aspirin plus ticagrelor."5.41Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice ( Chen, F; Chen, SL; Gao, DS; Gao, XF; Ge, Z; Han, YL; He, YQ; Kan, J; Kong, XQ; Li, F; Lin, S; Liu, ZZ; Qian, XS; Qu, H; Shao, YB; Tao, L; Tian, NL; Wang, Y; Wang, ZZ; Wen, SY; Xia, Y; Xiao, PX; Yang, Q; Yang, S; Ye, F; Zeng, HS; Zhang, JJ; Zuo, GF, 2021)
"Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine."5.34Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007)
"Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease."5.31Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report. ( Buyukberber, S; Sari, R; Sevinc, A, 2000)
"In the PRODIGY trial, prolonging clopidogrel-based DAPT beyond six months in elderly patients increased the risk of bleeding, without affording a significant prevention of ischaemic events."5.24Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial. ( Ariotti, S; Franzone, A; Gargiulo, G; Heg, D; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Tebaldi, M; Valgimigli, M; Windecker, S, 2017)
"Previous studies evaluating correlates of stent thrombosis (ST) have included mostly patients with bare metal stents and early-generation drug-eluting stents (DES) and have not systematically evaluated the role of intravascular ultrasound-guided stenting and high platelet reactivity on clopidogrel."5.20Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES. ( Brodie, BR; Garg, A; Kirtane, AJ; Maehara, A; Mehran, R; Metzger, DC; Neumann, FJ; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B, 2015)
"Rates of bleeding and thrombotic events were not significantly different according to 6- versus 24-month DAPT after PCI with new-generation DES in good aspirin responders."5.206- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. ( Armengaud, J; Barragan, P; Benamer, H; Berland, J; Blanchard, D; Boschat, J; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Druelles, P; Dupouy, P; Endresen, K; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J, 2015)
"This study aimed to compare preoperative treatment using clopidogrel and ticagrelor for patients with acute myocardial infarction (AMI) undergoing emergent percutaneous coronary intervention (PCI), and to investigate the efficacy and safety of these medications in the management of AMI."5.20Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Zhang, N; Zhang, Q; Zhu, K, 2015)
" Furthermore, the simpler dosing regimen, the absence of neutropenia, and the lower frequency of other side effects make it a safe alternative to ticlopidine."5.09Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. ( Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X, 1999)
"There were two episodes of thromboembolism in the ticlopidine group at 1 month and 6 months respectively, with a linearized incidence of 0."5.08Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. ( Agredo, J; Aramendi, JL; Larrarte, C; Llorente, A; Pijoan, J, 1998)
"Previous studies have shown that stents can be inserted in coronary arteries of patients who are subsequently treated safely with antiplatelet therapy only (ticlopidine and/or aspirin) with a low incidence of stent thrombosis, provided that stent expansion is adequate and there are no other flow-limiting lesions present."5.08Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. ( Albiero, R; Blengino, S; Colombo, A; Ferraro, M; Hall, P; Itoh, A; Martini, G; Nakamura, S, 1997)
" A 5-day course of ticlopidine HCl immediately before surgery results in a significant reduction in the thrombopenia usually observed and attributed to platelet aggregation and adhesion to the apparatus."5.05[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)]. ( Curtet, JM; Guilmet, D; Renner, C, 1980)
"It is unknown whether pretreatment with clopidogrel in acute coronary syndrome (ACS) managed invasively, is superior to a strategy of administering clopidogrel in the cardiac catheterization laboratory at the time of percutaneous coronary intervention (PCI)."4.95Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. ( Mukherjee, D; Naidu, SS; Nairooz, R; Pothineni, NV; Raina, S; Rochlani, Y; Sardar, P; Shavelle, DM; Valgimigli, M, 2017)
"Dual antiplatelet therapy with acetylsalicylic acid (aspirin) and clopidogrel is a guideline-recommended standard of care for patients with acute coronary syndromes (ACS) and those who undergo percutaneous coronary intervention (PCI)."4.88Clopidogrel: the data, the experience, and the controversies. ( Sadanandan, S; Singh, IM, 2012)
"In patients with acute coronary syndromes undergoing percutaneous coronary intervention, the combination of aspirin and clopidogrel, a P2Y12 adenosine diphosphate (ADP) receptor antagonist, is the gold standard of antiplatelet therapy."4.88Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention. ( Bessereau, J; Bonello, L; Camoin-Jau, L; Paganelli, F; Uhry, S, 2012)
" Premature withdrawal of dual antiplatelet therapy carries a substantial risk of stent thrombosis but perioperative continuation of dual antiplatelet therapy is associated with an increased risk of bleeding, particularly in patients treated with the new potent drugs prasugrel and ticagrelor."4.88[Platelet function: new drugs, new assays : possible impacts on operative medicine?]. ( Freynhofer, MK; Höchtl, T; Huber, K; Mahla, E; Prüller, F, 2012)
"Clopidogrel has become part of the mainstay of therapy for acute coronary syndromes and in patients post stenting."4.87Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy. ( Dart, AM; Fernando, H; Peter, K; Shaw, JA, 2011)
"The use of ticlopidine in association with aspirin has reduced the incidence of subacute stent thrombosis to currently < 1% after coronary stent implantation."4.82[Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?]. ( Baralis, G; Dellavalle, A; La Scala, E; Steffenino, G; Uslenghi, E, 2003)
"The present study is an investigation of the association between high on-treatment platelet reactivity to clopidogrel (HTPRC) and hepatosteatosis in patients who had elective stent implantation due to coronary artery disease."3.88Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation. ( Alper, AT; Barutca, H; Bora Şişman, S; Bozbeyoğlu, E; Çakıllı, Y; Çinier, G; Güzelburç, Ö; Şahin, S; Tekkeşin, Aİ; Velibey, Y; Yıldırımtürk, Ö, 2018)
"Variable response to clopidogrel can impact perioperative risk in elective endovascular intracranial aneurysm treatment."3.85Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response. ( Delgado Almandoz, JE; Fease, JL; Kayan, Y; Milner, AM; Mulder, M; Scholz, JM, 2017)
"There is a known bleeding risk with administration of the antiplatelet drug clopidogrel, but in certain patients the likelihood of thrombosis is too high to cease its administration perioperatively."3.81Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series. ( Bono, J; Nandi, S; Shubert, D, 2015)
"Although randomized clinical trials have compared clopidogrel with higher potency ADP receptor inhibitors (ADPris) among patients with myocardial infarction, little is known about the frequency and factors associated with switching between ADPris in clinical practice."3.80In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. ( Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y, 2014)
"The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown."3.80Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014)
" The aim of this study was to ascertain whether it is necessary to stop clopidogrel preoperatively to avoid postoperative complications following hip hemiarthroplasty surgery in patients with intracapsular hip fracture."3.79Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. ( Hossain, FS; Koch, L; Rambani, R; Ribee, H, 2013)
" The aim of this study was to investigate if platelet inhibition by clopidogrel has an influence on the formation of obliterative bronchiolitis, the histopathological correlate to bronchiolitis obliterans syndrome, present in the majority of patients suffering from CLAD."3.79Clopidogrel reduces post-transplant obliterative bronchiolitis. ( Eckl, S; Ensminger, SM; Koch, N; Preidl, RH; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M, 2013)
"In primary angioplasty, bivalirudin is superior to treatment with heparin plus glycoprotein inhibitors for reducing cardiovascular events, although bivalirudin increases the risk of stent thrombosis."3.79A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching. ( Acosta, J; Benezet, J; Cubero Gómez, JM; Díaz DE LA Llera, LS; Fernández-Cisnal, A; Parejo, J; Rangel, D; Zafra, F, 2013)
"Patients with recent acute coronary syndrome or percutaneous coronary intervention prescribed clopidogrel were offered CYP2C19 testing."3.79Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention. ( Brennan, T; Canestaro, WJ; Chaplin, D; Choudhry, NK; Desai, NR; Kyrychenko, P; Martell, LA; Matlin, OS, 2013)
" We aimed to determine the relationship between high on-treatment platelet reactivity (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel."3.78Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. ( Armero, S; Barragan, P; Berbis, J; Bessereau, J; Bonello, C; Bonello, L; Camillieri, E; Camoin-Jau, L; Dignat-George, F; Jacquin, L; Laine, M; Paganelli, F, 2012)
"To identify factors related to thromboembolic events during coil embolization for unruptured intracranial aneurysms and to evaluate the role of clopidogrel premedication to prevent thromboembolisms."3.76Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? ( Han, MH; Jung, C; Kang, HS; Kim, JE; Kwon, BJ; Kwon, OK; Oh, CW, 2010)
" The objective of this study is to assess the relationship between response to clopidogrel and post-treatment platelet reactivity (PPR) and 1-year major adverse cardiovascular events (MACE) in patients with non-ST segment elevation acute coronary syndrome (NSTEACS)."3.75Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome. ( Alonso Orcajo, N; Alonso Rodríguez, D; Carbonell de Blas, R; Cuellas Ramón, C; de Miguel Castro, A; Diego Nieto, A; Fernández Vázquez, F; Pascual Vicente, C; Pérez de Prado, A; Samaniego Lampón, B, 2009)
"The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt."3.73Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005)
" A significant increase in postoperative hemorrhage and a higher percentage of reoperations for this reason was observed in the patients treated with ticlopidine."3.67Ticlopidine as a hemorrhagic risk factor in coronary surgery. ( Avello, F; Carmona, J; Criado, A; Juffé, A; Otero, C, 1985)
"Myocardial infarction was assessed using the third universal definition."2.82Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. ( Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN, 2016)
"Our study offers preliminary evidence that patients receiving a new PCI procedure for ISR may benefit from long-term administration of aspirin plus clopidogrel."2.79Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). ( Biscaglia, S; Campo, G; Ferrari, R; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P, 2014)
" The PRASugrel For Japanese PatIenTs with Coronary Artery Diseases Undergoing Elective PCI (PRASFIT-Elective) study investigated the efficacy and safety of different prasugrel dosing regimens in Japanese patients undergoing elective PCI."2.79Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. ( Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H, 2014)
"Transplant renal artery stenosis is a major complication that requires a therapeutic approach involving surgery or angioplasty."2.77Angioplasty and stent treatment of transplant renal artery stenosis. ( Ballarín, J; Canal, C; de la Torre, P; Del Pozo, M; Díaz, JM; Facundo, C; Guirado, L; Martí, J, 2012)
"A cause other than paradoxical embolism was usually apparent in patients with recurrent neurologic events."2.77Closure or medical therapy for cryptogenic stroke with patent foramen ovale. ( Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L, 2012)
" Higher dosing strategies and methods to confirm platelet inhibition should be further investigated in order to optimally use clopidogrel in patients undergoing stenting."2.71The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. ( Bliden, KP; Gurbel, PA; Hayes, KM; Herzog, WR; Tantry, US; Yoho, JA, 2005)
"Ticlopidine pretreatment did not significantly influence the risk of death or myocardial infarction in patients randomized to abciximab."2.70Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. ( Ellis, SG; Lincoff, AM; Steinhubl, SR; Topol, EJ; Wolski, K, 2001)
"Probucol is a lipid-lowering drug that has an antioxidant effect."2.70Effect of antioxidant probucol for preventing stent restenosis. ( Cha, KS; Han, JY; Kim, HJ; Kim, JS; Kim, MH, 2002)
" Side-effects of ticlopidine were rare and patient management with the standard dosage of this drug was easier than oral anticoagulation."2.66Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion. ( Goebel, N; Krayenbühl, HP; Pfluger, N; Rothlin, ME; Senning, A; Speiser, K; Steinbrunn, W; Turina, M, 1985)
"Ticlopidine is an effective inhibitor of platelet aggregation."2.66Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. ( Gröntoft, KC; Gutierrez, A; Mulec, H; Olander, R, 1985)
" Combined major adverse cardiovascular event (stroke, MI, and death) was not different in the two groups (OR 1."2.47Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. ( Athanasiou, T; Malik, IS; Nijjer, SS; Watson, G, 2011)
"Intertrochanteric fractures are common in the elderly, who also suffer from a number of comorbidities."1.46Poor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort study. ( Chen, X; Liu, Z; Ren, J; Sun, T; Wang, J; Wang, X; Zhang, J, 2017)
"Oropharyngeal bleeding and dehydration were the most common reasons for unplanned readmission following TORS."1.46Unplanned readmission following transoral robotic surgery. ( Cognetti, DM; Curry, JM; Luginbuhl, A; Shumrick, C; Tassone, P; Topf, MC; Vo, A, 2017)
"Aspirin was continued in 25% of the cases."1.46Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy. ( Bensalah, K; Khene, Z; Mathieu, R; Peyronnet, B; Pradere, B; Roupret, M; Ruggiero, M; Seisen, T; Vaessen, C; Verhoest, G, 2017)
" The primary efficacy endpoint was major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, or stent thrombosis."1.43Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. ( Abizaid, A; Bhatt, DL; Chieffo, A; Colombo, A; Costa, RA; Feres, F; Genereux, P; Gilard, M; Giustino, G; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Leon, MB; Morice, MC; Palmerini, T; Park, KW; Redfors, B; Sardella, G; Sawaya, F; Stone, GW; Valgimigli, M, 2016)
"Six cases (6."1.43Complication of Stenting in Intracranial Arterial Stenosis. ( Liu, L; Zhang, F, 2016)
"Although frequent, hemoptysis is usually transient and minor."1.43Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy. ( Casutt, A; Koutsokera, A; Krueger, T; Lovis, A; Nicod, LP; Noetzli, J; Perentes, JY; Pons, M; Valenti, A, 2016)
"Despite recent advances in stent design and constantly improving protective pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI) are still major factors influencing morbidity and mortality."1.42Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up. ( Bulaeva, NI; Fortmann, S; Golukhova, EZ; Grigorian, MV; Ryabinina, MN; Serebruany, VL, 2015)
"Clopidogrel and ticlopidine, sometimes in combination with ASA, are associated with a low risk of bleeding during renal transplantation and does not seem to be a contraindication for renal transplant surgery."1.40Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. ( Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M, 2014)
"Unilateral vertebral artery dissection has been described in fewer than 40% of cases of RCVS."1.39Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. ( Do, HM; Mitchell, LA; Santarelli, JG; Singh, IP, 2013)
"Pocket hematoma is a troublesome complication associated with the implantation of cardiac implantable electronic devices (CIEDs)."1.39Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation. ( Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH, 2013)
"Onyx HD-500 is a liquid embolic used to treat intracranial aneurysms."1.39Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment. ( Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT, 2013)
"Aspirin was restarted on the first postoperative day and clopidogrel was restarted on the second postoperative day."1.38Perioperative management of a neurosurgical patient requiring antiplatelet therapy. ( Gregory Thompson, B; Rohatgi, P; Than, KD; Wilson, TJ, 2012)
"Stent thrombosis is not unusual in a post-operative setting."1.38Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis. ( Agnani, S; Akkus, NI; Rajpal, S, 2012)
"No choroidal or retrobulbar hemorrhages occurred in any patient."1.37Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. ( Albert, MA; Compton, CJ; Feist, RM; Frederick, PA; Gupta, SR; Heersink, MJ; Hill, ML; Mason, JO; Neimkin, MG; Thomley, ML; Vail, RS; White, MF, 2011)
"Only amlodipine was associated with clopidogrel poor-response."1.36The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. ( Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW, 2010)
"Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine."1.34Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007)
"Aspirin is an antiplatelet agent that acetylates cyclo-oxygenase and decreases the products of arachidonic acid metabolism, including thromboxane and prostacyclin."1.33Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats. ( Akan, M; Aköz, T; Cakir, B; Misirlioğlu, A; Taylan, G; Yildirim, S, 2005)
"Although saddle embolism is a relatively rare event, orthopaedic surgeons should be aware of this condition."1.33Saddle embolism after corrective femoral osteotomy: a case report. ( Hoshino, Y; Kariya, Y; Konishi, H; Noguchi, K; Ohashi, Y; Sekiya, H, 2006)
"Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease."1.31Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report. ( Buyukberber, S; Sari, R; Sevinc, A, 2000)
"Reduced anticoagulation with antiplatelet therapy alone after coronary stenting, despite infrequent use of intravascular ultrasound, is an effective and safe strategy with a low rate of vascular complications, a relatively short hospital stay and a low incidence of clinical manifestations of stent thrombosis."1.30Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice. ( Buller, CE; Chauhan, A; Moscovich, MD; Penn, IM; Ricci, DR; Zubaid, M, 1997)
"Hemorrhage was present in 9 cases of group B (21."1.30[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. ( Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ, 1997)
"Ticlopidine was withdrawn because of side effects in 11 patients."1.29[Treatment with ticlodipine after intracoronary stent implantation]. ( Golf, S; Myreng, Y; Mølstad, P, 1996)
"Ticlopidine appears to be an effective means of protecting graft patency as long as the biological effects of the drug are present."1.27Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. ( Chevigné, M; David, JL; Limet, R; Rigo, P, 1984)
"In 8 patients with liver cirrhosis who underwent hepatectomy, one patient with a prolonged T2 (260 secs) and a normal skin BT bled postoperatively, however, 3 patients with a prolonged skin BT (greater than 15 min) and a normal T2 had no hemorrhagic complications."1.27Clinical application of a new in vitro bleeding time device on surgical patients. ( Itoh, T; Kambayashi, J; Mori, T; Sakon, M; Tsujinaka, T; Uemura, Y, 1988)
" Nineteen out of them were treated with warfarin plus ticlopidine at a dosage enough to prolong the thrombo-test time to approximately 20% of normal value."1.27[Abnormalities of blood coagulation and effect of anticoagulant therapy in postoperative patients with lung cancer]. ( Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A; Tsurumi, T, 1986)

Research

Studies (313)

TimeframeStudies, this research(%)All Research%
pre-199019 (6.07)18.7374
1990's28 (8.95)18.2507
2000's91 (29.07)29.6817
2010's173 (55.27)24.3611
2020's2 (0.64)2.80

Authors

AuthorsStudies
Tomaniak, M1
Storey, RF1
Serruys, PW1
Ge, Z1
Gao, XF1
Kan, J1
Kong, XQ1
Zuo, GF1
Ye, F1
Tian, NL1
Lin, S1
Liu, ZZ1
Shao, YB1
He, YQ1
Wen, SY1
Yang, Q1
Xia, Y1
Wang, ZZ1
Xiao, PX1
Li, F1
Zeng, HS1
Yang, S1
Wang, Y2
Tao, L1
Gao, DS1
Qu, H1
Qian, XS1
Han, YL1
Chen, F1
Zhang, JJ1
Chen, SL1
Wu, X1
Liu, G1
Lu, J1
Zheng, XX1
Cui, JG1
Zhao, XY1
Huang, XH1
Benedetto, U1
Altman, DG1
Gerry, S1
Gray, A1
Lees, B1
Flather, M1
Taggart, DP1
Hansson, EC1
Jeppsson, A1
Abnousi, F1
Sundaram, V1
Yong, CM1
Prats, J2
Deliargyris, EN2
Stone, GW8
Hamm, CW3
Steg, PG2
Gibson, CM3
White, HD2
Price, MJ4
Généreux, P3
Desai, M1
Yang, L1
Ding, VY1
Harrington, RA2
Bhatt, DL7
Mahaffey, KW2
Pailleret, C1
Ait Hamou, Z1
Rosencher, N1
Samama, CM1
Eyraud, V1
Chilot, F1
Baillard, C1
Vaduganathan, M3
Zhang, J1
Chen, X1
Wang, J1
Liu, Z1
Wang, X2
Ren, J1
Sun, T1
Pearcy, C1
Almahmoud, K1
Jackson, T1
Hartline, C1
Cahill, A1
Spence, L1
Kim, D1
Olatubosun, O1
Todd, SR1
Campion, EM1
Burlew, CC1
Regner, J1
Frazee, R1
Michaels, D1
Dissanaike, S1
Stewart, C1
Foley, N1
Nelson, P1
Agrawal, V1
Truitt, MS1
Atay, SM1
Correa, AM1
Hofstetter, WL1
Mehran, RJ1
Rice, DC1
Roth, JA1
Sepesi, B1
Swisher, SG1
Vaporciyan, AA1
Walsh, G1
Antonoff, MB1
Topf, MC1
Vo, A1
Tassone, P1
Shumrick, C1
Luginbuhl, A1
Cognetti, DM1
Curry, JM1
Ozawa, T1
Suda, M1
Ikegami, R1
Takano, T1
Wakasugi, T1
Yanagawa, T1
Tanaka, K1
Ozaki, K1
Hirono, S1
Minamino, T1
Joo, HJ1
Ahn, SG1
Park, JH1
Park, JY1
Hong, SJ1
Kim, SY1
Choi, W1
Gwon, H1
Lim, YH1
Kim, W1
Kang, WC1
Cho, YH1
Kim, YH1
Yoon, J1
Shin, W1
Hong, MK2
Garg, S1
Jang, Y3
Lim, DS1
Consolo, F1
Pozzi, L1
Sferrazza, G1
Della Valle, P1
D'Angelo, A1
Slepian, MJ1
Pappalardo, F1
Velibey, Y1
Tekkeşin, Aİ1
Barutca, H1
Yıldırımtürk, Ö1
Bozbeyoğlu, E1
Çakıllı, Y1
Güzelburç, Ö1
Bora Şişman, S1
Çinier, G1
Şahin, S1
Alper, AT1
Wernly, B1
Lichtenauer, M1
Hoppe, UC1
Lauten, A1
Navarese, EP1
Jung, C2
Toba, T1
Shinke, T1
Otake, H1
Sugizaki, Y1
Takeshige, R1
Onishi, H1
Nagasawa, A1
Tsukiyama, Y1
Yanaka, K1
Nagano, Y1
Yamamoto, H1
Kawamori, H1
Matsuura, A1
Ishihara, T1
Matsumoto, D1
Igarashi, N1
Hayashi, T1
Yasaka, Y1
Kadotani, M1
Fujii, T1
Shite, J1
Okada, M1
Sakakibara, T1
Hirata, KI1
Lynch, DR1
Dantzler, D1
Robbins, M1
Zhao, D1
Chen, HC1
Chen, YL1
Guo, BF1
Tsai, TH1
Chang, JP1
Pan, KL1
Lin, YS1
Chen, MC1
Deo, SV1
Dunlay, SM1
Shah, IK1
Altarabsheh, SE1
Erwin, PJ1
Boilson, BA1
Park, SJ1
Joyce, LD1
Thapar, A1
Jenkins, IH1
Mehta, A1
Davies, AH1
Golan, S1
Levkovitch-Verbin, H1
Shemesh, G1
Kurtz, S1
Hossain, FS1
Rambani, R1
Ribee, H1
Koch, L1
McKenzie, JL1
Douglas, G1
Bazargan, A1
Tanrıkulu, A1
Ağırbaşlı, M1
Lamberts, M1
Gislason, GH1
Olesen, JB1
Kristensen, SL1
Schjerning Olsen, AM1
Mikkelsen, A1
Christensen, CB1
Lip, GY1
Køber, L1
Torp-Pedersen, C1
Hansen, ML1
López, J1
Morales, C1
Avanzas, P1
Callejo, F1
Hernández-Vaquero, D1
Llosa, JC1
Preidl, RH1
Eckl, S1
Ramsperger-Gleixner, M1
Koch, N1
Spriewald, BM1
Weyand, M1
Ensminger, SM1
Díaz DE LA Llera, LS1
Cubero Gómez, JM1
Rangel, D1
Parejo, J1
Acosta, J1
Fernández-Cisnal, A1
Zafra, F1
Benezet, J1
Callender, R1
Altamirano, A1
Tezino, T1
Pivalizza, EG1
Cattano, D1
Müller, KA1
Karathanos, A1
Tavlaki, E1
Stimpfle, F1
Meissner, M1
Bigalke, B1
Stellos, K1
Schwab, M1
Schaeffeler, E1
Müller, II1
Gawaz, M1
Geisler, T1
Campo, G2
Tebaldi, M3
Vranckx, P2
Biscaglia, S1
Tumscitz, C1
Ferrari, R1
Valgimigli, M7
Desai, NR1
Canestaro, WJ1
Kyrychenko, P1
Chaplin, D1
Martell, LA1
Brennan, T1
Matlin, OS1
Choudhry, NK1
Benahmed, A1
Kianda, M1
Ghisdal, L1
Broeders, N1
Massart, A1
Lemy, A1
Mikhalski, D1
Hoang, AD1
Donckier, V1
Sadis, C1
Le Moine, A1
Madhoun, P1
Racapé, J1
Wissing, M1
Abramowicz, D1
Ariyaratnam, P1
McLean, LA1
Kotidis, K1
Loubani, M1
Miceli, A2
Angelini, GD2
Rubino, AS1
Della Corte, A1
Giordano, R1
Menicanti, L1
Gasparovic, H1
Petricevic, M2
Kopjar, T1
Djuric, Z1
Svetina, L2
Biocina, B2
Murray, AM1
Keville, N1
Gray, S1
Kashiwazaki, D1
Kuwayama, N1
Akioka, N1
Hayakawa, Y1
Kuroda, S1
Olivier, CB1
Schnabel, K1
Brandt, C1
Weik, P1
Olschewski, M2
Zhou, Q1
Bode, C1
Diehl, P1
Moser, M1
Parekh, P1
Agrawal, N1
Vasavada, A1
Vinchurkar, M1
Kasivisvanathan, R1
Abbassi-Ghadi, N1
Kumar, S1
Mackenzie, H1
Thompson, K1
James, K1
Mallett, SV1
Bagai, A1
Wang, TY1
Curtis, JP1
Gurm, HS1
Shah, B1
Cheema, AN1
Peterson, ED2
Saucedo, JF1
Granger, CB1
Roe, MT1
McNamara, RL1
Alexander, KP1
Daels, FP1
Gaizauskas, A1
Rioja, J1
Varshney, AK1
Erkan, E1
Ozgok, Y1
Melekos, M1
de la Rosette, JJ1
Une, D1
Al-Atassi, T1
Kulik, A2
Voisine, P1
Le May, M1
Ruel, M2
Hess, CN1
Lopes, RD2
Hager, R1
Wojdyla, DM1
Englum, BR1
Mack, MJ1
Califf, RM1
Kouchoukos, NT1
Alexander, JH2
Patel, PA1
Fleisher, LA1
Pinnarelli, L1
Mayer, F1
Bauleo, L1
Agabiti, N1
Kirchmayer, U1
Belleudi, V1
Di Martino, M1
Autore, C1
Ricci, R1
Violini, R1
Fusco, D1
Davoli, M1
Perucci, CA1
Isshiki, T2
Kimura, T1
Ogawa, H1
Yokoi, H1
Nanto, S1
Takayama, M1
Kitagawa, K1
Nishikawa, M1
Miyazaki, S1
Ikeda, Y1
Nakamura, M1
Saito, S1
Anderson, K1
Jupiter, DC1
Abernathy, SW1
Frazee, RC1
Gilard, M2
Barragan, P3
Noryani, AAL1
Noor, HA1
Majwal, T1
Hovasse, T1
Castellant, P1
Schneeberger, M1
Maillard, L1
Bressolette, E1
Wojcik, J1
Delarche, N1
Blanchard, D1
Jouve, B1
Ormezzano, O1
Paganelli, F3
Levy, G1
Sainsous, J2
Carrie, D1
Furber, A1
Berland, J1
Darremont, O1
Le Breton, H1
Lyuycx-Bore, A1
Gommeaux, A1
Cassat, C1
Kermarrec, A1
Cazaux, P1
Druelles, P1
Dauphin, R1
Armengaud, J1
Dupouy, P1
Champagnac, D1
Ohlmann, P1
Endresen, K1
Benamer, H1
Kiss, RG1
Ungi, I2
Boschat, J1
Morice, MC4
Garg, P1
Galper, BZ1
Cohen, DJ1
Yeh, RW1
Mauri, L2
Patialiakas, A1
Thury, A1
McFadden, E1
Colangelo, S1
Tondi, S1
Roffi, M1
Menozzi, A1
de Cesare, N1
Garbo, R1
Meliga, E2
Testa, L2
Gabriel, HM1
Airoldi, F2
Ferlini, M1
Liistro, F1
Dellavalle, A2
Briguori, C1
Kandzari, DE1
Rosencher, J1
Gouffran, G1
Bougouin, W1
Varenne, O1
Gandhi, S1
Schwalm, JD1
Velianou, JL1
Natarajan, MK1
Farkouh, ME2
Ginsel, BL1
Taher, A1
Whitehouse, SL1
Bell, JJ1
Pulle, CR1
Crawford, RW1
Shubert, D1
Bono, J1
Nandi, S1
Yudi, MB1
Eccleston, D1
Andrianopoulos, N1
Farouque, O1
Duffy, SJ1
Brennan, A1
Reid, C1
Clark, DJ1
Ajani, AE1
Madhavan, MV1
Kirtane, AJ5
Xu, K3
Witzenbichler, B4
Mehran, R5
Ong, WL1
Koh, TL1
Fletcher, J1
Gruen, R1
Royce, P1
Capranzano, P1
Castiglioni, B1
Siasos, G1
Oikonomou, E1
Zaromitidou, M1
Kioufis, S1
Kokkou, E1
Mourouzis, K1
Vlasis, K1
Vavuranakis, M1
Stone, PH1
Papavassiliou, AG1
Tousoulis, D1
Pottegård, A1
García Rodríguez, LA1
Poulsen, FR1
Hallas, J1
Gaist, D1
Golukhova, EZ1
Grigorian, MV1
Ryabinina, MN1
Bulaeva, NI1
Fortmann, S1
Serebruany, VL1
Wong, P1
Tesoro, E1
Aletich, V1
Alaraj, A2
Brodie, BR3
Garg, A1
Stuckey, TD3
Maehara, A3
Weisz, G3
Rinaldi, MJ3
Neumann, FJ5
Metzger, DC3
Parvataneni, R3
Smilowitz, NR3
Henry, TD2
Cox, DA2
Duffy, PL2
Mazzaferri, EL2
Yahagi, K1
Virmani, R1
Kesavamoorthy, B1
Kim, JY1
Choi, YS1
Kwon, A1
Chung, WB1
Park, CS1
Kim, HY1
Chang, K1
Lee, MY1
Chung, WS1
Seung, KB1
Yang, H1
Li, Y1
Jiang, Y1
Hunter, JB1
Carlson, ML1
Sweeney, AD1
Tombers, NM1
Wanna, GB1
Driscoll, CL1
Haynes, DS1
Zhu, K1
Fu, Q1
Zhang, N1
Huang, YJ1
Zhang, Q1
Valenti, A1
Casutt, A1
Koutsokera, A1
Noetzli, J1
Perentes, JY1
Krueger, T1
Pons, M1
Nicod, LP1
Lovis, A1
Purushothaman, B1
Webb, M1
Weusten, A1
Bonczek, S1
Ramaskandhan, J1
Nanu, A1
Wąsowicz, M1
Syed, S1
Wijeysundera, DN1
Starzyk, Ł1
Grewal, D1
Ragoonanan, T1
Harsha, P1
Travis, G1
Carroll, J1
Karkouti, K1
Beattie, WS1
Nijenhuis, VJ1
Bennaghmouch, N1
Hassell, M1
Baan, J1
van Kuijk, JP2
Agostoni, P2
van 't Hof, A1
Kievit, PC1
Veenstra, L1
van der Harst, P1
van den Heuvel, AF1
den Heijer, P1
Kelder, JC3
Deneer, VH3
van der Kley, F1
Onorati, F1
Collet, JP4
Maisano, F1
Latib, A2
Huber, K2
Stella, PR1
Ten Berg, JM4
Pacheco, C1
Aguilar, M1
Potter, BJ1
Watanabe, Y1
Kozuma, K1
Ishikawa, S1
Hosogoe, N1
Berger, JS1
Hummel, T1
Meves, SH1
Rüdiger, K1
Mügge, A1
Mumme, A1
Burkert, B1
Mühlberger, D1
Neubauer, H1
Oltmann, SC1
Alhefdhi, AY1
Rajaei, MH1
Schneider, DF1
Sippel, RS1
Chen, H1
Chandrasekhar, J1
Baber, U1
Sartori, S1
Faggioni, M1
Aquino, M1
Kini, A1
Weintraub, W1
Rao, S1
Kapadia, S1
Weiss, S1
Strauss, C1
Toma, C1
Muhlestein, B1
DeFranco, A1
Effron, M1
Keller, S1
Baker, B1
Pocock, S1
Henry, T1
Zhang, F1
Liu, L1
Dadjou, Y1
Safavi, S1
Kojuri, J1
Morici, N1
Perna, E1
Cipriani, M1
Femia, EA1
Oliva, F1
Frigerio, M1
Cattaneo, M1
Kayan, Y1
Delgado Almandoz, JE1
Fease, JL1
Milner, AM1
Scholz, JM1
Mulder, M1
Westerman, ME1
Sharma, V1
Scales, J1
Gearman, DJ1
Ingimarsson, JP1
Krambeck, AE1
Essandoh, MK1
Dalia, AA1
George, BS1
Flores, AS1
Otey, AJ1
Broderick, TM1
Rao, SV1
Prates, PR1
Williams, JB1
Mehta, RH1
Stevens, SR1
Thomas, L1
Smith, PK1
Newby, LK1
Kalil, RA1
Giustino, G1
Chieffo, A2
Palmerini, T1
Feres, F1
Abizaid, A1
Costa, RA1
Kim, BK1
Kim, HS3
Park, KW2
Sawaya, F1
Sardella, G1
Redfors, B1
Leon, MB2
Colombo, A6
Pradere, B1
Peyronnet, B1
Seisen, T1
Khene, Z1
Ruggiero, M1
Vaessen, C1
Verhoest, G1
Mathieu, R1
Roupret, M1
Bensalah, K1
Sedat, J1
Chau, Y1
Gaudart, J1
Sachet, M1
Beuil, S1
Lonjon, M1
Fichter, AM1
Ritschl, LM1
Robitzky, LK1
Wagenpfeil, S1
Mitchell, DA1
Wolff, KD1
Mücke, T1
Nairooz, R1
Rochlani, Y1
Pothineni, NV1
Raina, S1
Sardar, P1
Mukherjee, D1
Naidu, SS1
Shavelle, DM1
Piccolo, R1
Magnani, G1
Ariotti, S1
Gargiulo, G1
Marino, M1
Santucci, A1
Franzone, A1
Heg, D1
Windecker, S1
van Diepen, S1
Fuster, V1
Verma, S1
Hamza, TH1
Siami, FS1
Goodman, SG1
Saydam, F1
Değirmenci, İ1
Birdane, A1
Özdemir, M1
Ulus, T1
Özbayer, C1
Çolak, E1
Ata, N1
Güneş, HV1
Hudec, V1
Bena, M1
Artemiou, P1
Gasparovic, I1
Hulman, M1
Nakagawa, I2
Park, HS1
Wada, T1
Yokoyama, S1
Yamada, S1
Motoyama, Y1
Kichikawa, K1
Nakase, H1
Shim, CY1
Yoon, SJ1
Park, S1
Kim, JS2
Choi, JR1
Ko, YG1
Choi, D1
Ha, JW1
Chung, N1
Shim, WH1
Cho, SY1
Johansen, A1
White, J1
Turk, A2
Barthwal, R1
Herman, BA1
Patel, RA1
White, CJ1
Gumina, RJ1
Yang, EH1
Sandhu, GS1
Prasad, A1
Bresnahan, JF1
Lennon, RJ1
Rihal, CS1
Holmes, DR2
Singh, M1
McKellar, SH1
Thompson, JL1
Garcia-Rinaldi, RF1
Macdonald, RJ1
Sundt, TM1
Schaff, HV1
Alfonso, F1
Pérez-Vizcayno, MJ1
Hernández, R1
Bethencourt, A1
Martí, V1
López-Mínguez, JR1
Angel, J1
Iñiguez, A1
Morís, C1
Cequier, A1
Sabaté, M1
Escaned, J1
Jiménez-Quevedo, P1
Bañuelos, C1
Suárez, A1
Macaya, C1
Demaret, C1
Crousier, M1
Hanss, M1
Ffrench, P1
Piriou, V1
de Miguel Castro, A1
Cuellas Ramón, C1
Diego Nieto, A1
Samaniego Lampón, B1
Alonso Rodríguez, D1
Fernández Vázquez, F1
Alonso Orcajo, N1
Carbonell de Blas, R1
Pascual Vicente, C1
Pérez de Prado, A1
Chan, V1
Argüello Viudez, L1
Rogacka, R1
Michev, I1
Cosgrave, J1
Montorfano, M1
Carlino, M1
Sangiorgi, GM1
Castelli, A1
Godino, C1
Magni, V1
Aranzulla, TC1
Romagnoli, E1
Pecot, CV1
Fuller, M1
Muldowney, JA1
Misra, S1
Ruthmann, O1
Seitz, A1
Richter, S1
Marjanovic, G1
Hopt, UT1
Fischer, A1
Schrag, HJ1
Gao, C1
Ren, C1
Li, D1
Li, L1
Natarajan, SK1
Snyder, KV1
Siddiqui, AH1
Ionita, CC1
Hopkins, LN1
Levy, EI1
Tetik, S1
Ak, K1
Isbir, S1
Eksioglu-Demiralp, E1
Arsan, S1
Iqbal, O1
Yardimci, T1
Motovska, Z1
Widimsky, P1
Bae, JP1
Dobesh, PP1
McCollam, PL1
Khoynezhad, A1
Chatterjee, T1
Akin, I1
Rehders, TC1
Chatterjee, A1
Schüpfer, C1
Nienaber, CA1
Ince, H1
Kim, DH1
Daskalakis, C1
Silvestry, SC1
Sheth, MP1
Lee, AN1
Adams, S1
Hohmann, S1
Medvedev, S1
Whellan, DJ1
Sielski, J1
Wałek, P1
Polewczyk, A1
Janion, M1
Nesher, N1
Singh, SK1
Fawzy, HF1
Sever, JY1
Goldman, BE1
Cohen, GN1
Laflamme, C1
Fremes, SE1
Wait, SD1
Abla, AA1
Killory, BD1
Starke, RM1
Spetzler, RF1
Nakaji, P1
Kramer, E1
Hadad, E1
Westreich, M1
Shalom, A1
Breet, NJ3
van Werkum, JW2
Bouman, HJ1
Ruven, HJ2
Bal, ET1
Harmsze, AM2
van der Heyden, JA1
Rensing, BJ1
Suttorp, MJ1
Hackeng, CM2
Osta, WA1
Akbary, H1
Fuleihan, SF1
Doraiswamy, VA1
García-Bracamonte, B1
Vanaclocha, F1
Robijns, K1
Klungel, OH1
de Boer, A1
Ho, PM1
Tsai, TT1
Maddox, TM1
Powers, JD1
Carroll, NM1
Jackevicius, C1
Go, AS1
Margolis, KL1
DeFor, TA1
Rumsfeld, JS1
Magid, DJ1
Anselmino, M1
Moretti, C2
Ravera, L1
Sheiban, I2
Sharpe, RY1
Dennis, MJ1
Nasim, A1
McCarthy, MJ1
Sayers, RD1
London, NJ2
Naylor, AR3
Nydick, JA1
Farrell, ED1
Marcantonio, AJ1
Hume, EL1
Marburger, R1
Ostrum, RF1
Möllmann, H1
Nef, HM1
Kalyanasundaram, A1
Berger, PB3
Hodgson, RE1
Miller, SM1
Fortuna, A1
Harrison, GR1
Bellemain-Appaix, A1
Brieger, D1
Beygui, F2
Silvain, J1
Pena, A1
Cayla, G1
Barthélémy, O1
Montalescot, G3
Gandhi, NK1
Abdel-Karim, AR1
Banerjee, S1
Brilakis, ES1
Voute, MT1
Flu, WJ1
Schouten, O1
Chonchol, M1
Hoeks, SE1
Boersma, EE1
Verhagen, HJ1
Bax, JJ1
Poldermans, D1
Kang, HS1
Han, MH1
Kwon, BJ1
Kim, JE1
Kwon, OK1
Oh, CW1
Mason, JO1
Gupta, SR1
Compton, CJ1
Frederick, PA1
Neimkin, MG1
Hill, ML1
Heersink, MJ1
Vail, RS1
White, MF1
Feist, RM1
Thomley, ML1
Albert, MA1
Fernández-Sender, L1
Martínez-Cerezo, FJ1
Amorós, S1
Tena, FJ1
Marsal, J1
Pascual, D1
Suh, JW1
Lee, SP1
Lee, HY1
Kang, HJ1
Koo, BK1
Cho, YS1
Youn, TJ1
Chae, IH1
Choi, DJ1
Rha, SW1
Bae, JH1
Kwon, TG1
Bae, JW1
Cho, MC1
Bonatti, J1
Zimrin, D1
Suissa, S1
Savage, EB1
Geara, AS1
Ayoub, I1
Abi Rached, J1
Siddique, MN1
Ghimire, P1
El-Sayegh, S1
Klisch, J1
Turner, R1
Woo, HH1
Fiorella, D1
Morofuji, Y1
So, G1
Hiu, T1
Kawakubo, J1
Hayashi, K1
Kitagawa, N1
Morikawa, M1
Suyama, K1
Nagata, I1
Cook-Norris, RH1
Michaels, JD1
Weaver, AL1
Phillips, PK1
Brewer, JD1
Roenigk, RK1
Otley, CC1
Fernando, H1
Dart, AM1
Peter, K1
Shaw, JA1
Satler, LF1
Nijjer, SS1
Watson, G1
Athanasiou, T1
Malik, IS1
Barequet, IS1
Sachs, D1
Shenkman, B1
Priel, A1
Wasserzug, Y1
Budnik, I1
Moisseiev, J1
Salomon, O1
Bordeaux, JS1
Martires, KJ1
Goldberg, D1
Pattee, SF1
Fu, P1
Maloney, ME1
Duggie, AJ1
Dimech, J1
Brown, JS1
Mahmoud, TH1
Nwachuku, IC1
Jones, M1
Clough, TM1
Cardona, L1
Ana, G1
Luísa, B1
Leal, A1
António, F1
Lídia, S1
Cruz, FR1
Mascarenhas, L1
Brar, SS1
ten Berg, J1
Marcucci, R1
Patti, G2
DiSciascio, G1
Cuisset, T2
Dangas, G2
Wiviott, SD1
Hochholzer, W1
Parrett, BM1
Woo, A1
Buntic, R1
Singer, M1
Brizzio, ME1
Shaw, RE1
Bosticco, B1
Collins, M2
Grau, JB1
Mak, AW1
Zapolanski, A1
Akkus, NI1
Rajpal, S1
Agnani, S1
Malik, AI1
Foster, RE1
Correa, ZM1
Petersen, MR1
Miller, DM1
Riemann, CD1
Jaitner, J1
Morath, T1
Byrne, RA1
Braun, S1
Gebhard, D1
Bernlochner, I1
Schulz, S1
Mehilli, J1
Schömig, A4
Koch, W1
Kastrati, A3
Sibbing, D1
Furlan, AJ1
Reisman, M1
Massaro, J1
Adams, H1
Albers, GW1
Felberg, R1
Herrmann, H1
Kar, S1
Landzberg, M1
Raizner, A1
Wechsler, L1
Kiviniemi, T1
Karjalainen, P1
Pietilä, M1
Ylitalo, A1
Niemelä, M1
Vikman, S1
Puurunen, M1
Biancari, F1
Airaksinen, KE1
Bonello, L2
Berbis, J1
Laine, M1
Armero, S1
Bessereau, J2
Jacquin, L1
Bonello, C1
Camillieri, E1
Dignat-George, F1
Camoin-Jau, L2
Kizilkilic, O1
Kocer, N1
Metaxas, GE1
Babic, D1
Homan, R1
Islak, C1
Uhry, S1
Al Khudairy, A1
Al-Mallah, JM1
Al-Hadeedi, O1
Sayana, MK1
Mrdovic, I1
Savic, L1
Krljanac, G1
Asanin, M1
Perunicic, J1
Antonijevic, N1
Lasica, R1
Marinkovic, J1
Kocev, N1
Vasiljevic, Z1
Mahla, E1
Höchtl, T1
Prüller, F1
Freynhofer, MK1
Mangiacapra, F1
Barbato, E1
Orlic, D1
Peace, AJ1
D'Ambrosio, A1
Ostojic, M1
Wijns, W1
Di Sciascio, G2
Duggan, SM1
Aresu, G1
de Siena, PM1
Romeo, F1
Glauber, M1
Caputo, M1
Than, KD1
Rohatgi, P1
Wilson, TJ1
Gregory Thompson, B1
Del Pozo, M1
Martí, J1
Guirado, L1
Facundo, C1
Canal, C1
de la Torre, P1
Ballarín, J1
Díaz, JM1
Fujikawa, T1
Maekawa, H1
Shiraishi, K1
Tanaka, A1
Sadanandan, S1
Singh, IM1
Bötticher, G1
Gäbel, G1
Weiss, N1
Saeger, HD1
Bergert, H1
Liang, GZ1
Zhang, FX1
Luo, XY1
Zhang, CM1
Hu, L1
Feng, YP1
Niu, LY1
Zhang, H1
Ma, BB1
Qi, HS1
Guo, MM1
Long, YY1
Li, HL1
Milicic, D1
Carlson, AP1
Amin-Hanjani, S1
Charbel, FT1
Aletich, VA1
Riml, S1
Wallner, H1
Kompatscher, P1
Mitchell, LA1
Santarelli, JG1
Singh, IP1
Do, HM1
Turpie, AG1
Hiller, E1
Timperley, J1
Clarke, NR1
Banning, AP1
Kim, MH1
Cha, KS1
Han, JY1
Kim, HJ1
Alam, M1
Goldberg, LH1
Mueller, C1
Roskamm, H2
Hunziker, P1
Marsch, S1
Perruchoud, A1
Buettner, HJ1
Rott, D1
Jessup, DB1
Coletti, AT1
Muhlestein, JB1
Barry, WH1
Shean, FC1
Whisenant, BK1
Baralis, G1
Steffenino, G1
La Scala, E1
Uslenghi, E1
Hui, AJ1
Wong, RM1
Ching, JY1
Hung, LC1
Chung, SC1
Sung, JJ1
Moses, JW2
Ludwig, J1
Spanos, V1
Louvard, Y1
Desmedt, B1
Di Mario, C2
Payne, DA2
Jones, CI2
Hayes, PD2
Thompson, MM1
Bell, PR1
Goodall, AH2
Schömig, E1
Ferguson, JJ1
van der Heijden, DJ1
Westendorp, IC1
Riezebos, RK1
Kiemeneij, F1
Slagboom, T1
van der Wieken, LR1
Laarman, GJ1
Stadius, ML1
Casselman, FP1
Meco, M1
Dom, H1
Foubert, L1
Van Praet, F1
Vanermen, H1
Ernst, NM1
Suryapranata, H1
Miedema, K1
Slingerland, RJ1
Ottervanger, JP1
Hoorntje, JC1
Gosselink, AT1
Dambrink, JH1
de Boer, MJ1
Zijlstra, F1
van 't Hof, AW1
Klima, U1
MacVaugh, H1
Bagaev, E1
Maringka, M1
Kirschner, S1
Beilner, J1
Haverich, A1
Sharma, SK1
Choudhury, A1
Lee, J1
Kim, MC1
Fisher, E1
Steinheimer, AM1
Kini, AS1
Chu, MW1
Wilson, SR1
Novick, RJ1
Stitt, LW1
Quantz, MA1
Kapetanakis, EI1
Medlam, DA1
Boyce, SW1
Haile, E1
Hill, PC1
Dullum, MK1
Bafi, AS1
Petro, KR1
Corso, PJ1
Bavry, AA1
Kumbhani, DJ1
Helton, TJ1
Akan, M1
Cakir, B1
Misirlioğlu, A1
Yildirim, S1
Taylan, G1
Aköz, T1
Gurbel, PA1
Bliden, KP1
Hayes, KM1
Yoho, JA1
Herzog, WR1
Tantry, US1
Wood, F1
Bazemore, E1
Schneider, JE1
Jobe, RL1
Mann, T1
Gluckman, TJ1
Rade, JJ1
Schulman, SP1
Sharifi, M1
Dehghani, M1
Mehdipour, M1
Al-Bustami, O1
Emrani, F1
Burks, J1
Cay, S1
Yilmaz, MB1
Korkmaz, S1
Wilmshurst, PT1
Nightingale, S1
Walsh, KP1
Morrison, WL1
Eriksson, P1
Wanke, I1
Doerfler, A1
Goericke, S1
Gizewski, ER1
Sandalcioglu, E1
Moemken, S1
Stolke, D1
Forsting, M1
Hitos, K1
Fletcher, JP1
García-Rinaldi, R1
Steinhubl, SR2
Brennan, DM1
Topol, EJ3
Klutmann, M1
Tillmanns, C1
Gulba, DC1
Le Feuvre, C1
Batisse, A1
Batisse, JP1
Choussat, R1
Helft, G1
Metzger, JP1
Sekiya, H1
Noguchi, K1
Ohashi, Y1
Kariya, Y1
Hoshino, Y1
Konishi, H1
Potapov, EV1
Hetzer, R1
Collins, P1
Ford, I1
Greaves, M1
Macaulay, E1
Brittenden, J1
McAllister, RK1
Dehmer, GJ1
Meyer, TA1
Digne, F1
Gérardin, B1
Pillière, R1
Estagnasié, P1
Dib, JC1
Terdjman, M1
Grinda, JM1
Dubois, C1
Tomita, H1
Hatakeyama, K1
Soda, W1
Kobayashi, T1
Ziegelin, M1
Hoschtitzky, A1
Dunning, J1
Hooper, T1
Spiess, BD1
van der Linden, J1
Augoustides, JG1
Lotrionte, M1
Biondi-Zoccai, GG1
Abbate, A1
Angiolillo, DJ1
Alessi, MC1
Waksman, R1
Sangiorgi, G1
Laudito, A1
Trevi, GP1
Lavelle, WF1
Demers Lavelle, EA1
Uhl, R1
Sokurenko, GIu1
Luk'ianov, IuV1
Parusova, EV1
Edovina, LN1
Limet, R2
David, JL2
Rigo, P2
Lapeyrère, X1
Gruyer, P1
Guyot, L1
Barbe, G1
Saint-Paul, B1
Chevigné, M1
Mayumi, T1
Dohi, S1
Davies, JA1
Tindall, H1
Paton, RC1
Menys, VC1
Doig, RL1
Kester, RC1
McNicol, GP1
Brommer, EJ1
Renner, C1
Guilmet, D1
Curtet, JM1
Van Belle, E1
McFadden, EP1
Lablanche, JM1
Bauters, C1
Hamon, M1
Bertrand, ME1
Schühlen, H2
Blasini, R1
Hadamitzky, M2
Walter, H2
Zitzmann-Roth, EM1
Richardt, G1
Alt, E1
Schmitt, C1
Ulm, K2
Lo, CY1
Cheng, IK1
Tso, WK1
Mak, KO1
Myreng, Y1
Mølstad, P1
Golf, S1
Goods, CM1
al-Shaibi, KF1
Liu, MW1
Yadav, JS1
Mathur, A1
Jain, SP1
Dean, LS1
Iyer, SS1
Parks, JM1
Roubin, GS1
Pan, M1
Suárez de Lezo, J1
Velasco, F1
Romero, M1
Medina, A1
Segura, J1
Hernández, E1
Pavlovic, D1
Melian, F1
Gallardo, A1
Zayas, R1
Ruiz, M1
Torres, A1
Albiero, R1
Hall, P1
Itoh, A1
Blengino, S1
Nakamura, S1
Martini, G1
Ferraro, M2
Zubaid, M1
Penn, IM1
Buller, CE1
Moscovich, MD1
Ricci, DR1
Chauhan, A1
Silvestri, M1
Simeoni, JB1
Bayet, G1
Roquebert, PO1
Bouvier, JL1
Comet, B1
Quatre, JM1
Linnemeier, TJ1
Reimers, B1
Reinhardt, R1
Moussa, I2
Iturbe, T1
Sánchez, C1
Moreno, JA1
Olave, T1
Azaceta, G1
Varo, MJ1
Civeira, E1
Peleato, J1
Cornudella, R1
Feldman, TE1
Oemrawsingh, PV2
Tuinenburg, JC1
Schalij, MJ2
Jukema, JW1
Reiber, JH1
Bruschke, AV2
Udayachalerm, W1
van der Wall, EE1
Alvarez, JM1
Harper, RW1
Peverill, RE1
Madan, M1
Marquis, JF1
de May, MR1
Laramee, LA1
Leddy, D1
O'Brien, E1
Williams, WL1
Higginson, LA1
Jelley, J1
Reid, F1
Johansen, H1
Labinaz, M1
Zidar, JP1
Aramendi, JL1
Agredo, J1
Llorente, A1
Larrarte, C1
Pijoan, J1
Reffelmann, T1
vom Dahl, J1
Hendriks, F1
Klues, HG1
Hanrath, P1
Oetgen, M1
Roubin, G1
Iyer, S1
Maida, R1
Kreps, E1
Bennett, CL1
Davidson, CJ1
Green, D1
Weinberg, PD1
Feldman, MD1
McCullough, PA1
Marks, KR1
Jafary, FH1
Kimmelstiel, CD1
Müller, C1
Büttner, HJ1
Petersen, J1
Miller, JL1
Van Langenhove, G1
Vermeersch, P1
Serrano, P1
Kutryk, MJ1
Stockman, D1
Convens, C1
Van den Branden, F1
Vanagt, E1
Albertal, M1
Van den Heuvel, P1
Kobza, II1
Sannes, MR1
Modi, KS1
Sari, R1
Sevinc, A1
Buyukberber, S1
Kleiman, NS1
Grazeiadei, N1
Maresh, K1
Taylor, RJ1
Frederick, B1
Lance, ET1
Effron, MB1
Jordan, RE1
Mascelli, MA1
Calver, AL1
Blows, LJ1
Harmer, S1
Dawkins, KD1
Gray, HH1
Morgan, JH1
Simpson, IA1
Chew, DP1
Hirsch, AT1
Ringleb, PA1
Hacke, W1
Ellis, SG1
Wolski, K1
Lincoff, AM1
Hutten, BA1
Verheugt, FW1
Plokker, HW1
Tanabe, Y1
Ito, E1
Suzuki, K1
Griffo, R1
De Servi, S1
Yende, S1
D'Ancona, G1
Donias, HW1
Karamanoukian, RL1
Bergsland, J1
Karamanoukian, HL1
Bartorelli, AL1
Trabattoni, D1
Montorsi, P1
Fabbiocchi, F1
Galli, S1
Ravagnani, P1
Grancini, L1
Cozzi, S1
Loaldi, A1
Vera, M1
Pou, M1
Botey, A1
Cases, A1
Saitoh, H2
Matsumoto, H1
Takayama, T2
Ide, H1
Miyawaki, F1
Furuse, A1
Tsujinaka, T1
Itoh, T1
Uemura, Y1
Sakon, M1
Kambayashi, J1
Mori, T1
Shiguma, S1
Tachibana, S1
Asada, K1
Ohzeki, M1
Sasaki, S1
Takeuchi, A1
Ogawa, J1
Tsurumi, T1
Inoue, H2
Koide, S1
Kawada, S1
Shohtsu, A1
Binaghi, F1
Fronteddu, PF1
Cannas, F1
Martelli, V1
Kudo, T1
Shimizu, T1
Kawachi, K1
Konagai, N1
Hino, H1
Furukawa, K1
Harker, LA1
Rothlin, ME1
Pfluger, N1
Speiser, K1
Goebel, N1
Krayenbühl, HP1
Steinbrunn, W1
Turina, M1
Senning, A1
Gröntoft, KC1
Mulec, H1
Gutierrez, A1
Olander, R1
Criado, A1
Juffé, A1
Carmona, J1
Otero, C1
Avello, F1

Clinical Trials (41)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents Guided by Either Intravascular Ultrasound or Angiography in Patients With Acute Coronary Syndrome: The Prospective, Multicenter, Randomized, Placebo-[NCT03971500]3,710 participants (Actual)Interventional2019-08-20Active, not recruiting
Analysis of the Platelet Activity State in Patients Implanted With Ventricular Assist Device (VAD)[NCT03255928]60 participants (Anticipated)Observational [Patient Registry]2017-06-29Recruiting
PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY[NCT00611286]Phase 41,700 participants (Anticipated)Interventional2006-12-31Completed
Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting[NCT01159639]Phase 4200 participants (Actual)Interventional2010-06-30Completed
Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm[NCT02527044]120 participants (Anticipated)Interventional2015-11-30Active, not recruiting
Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423]Phase 2113 participants (Actual)Interventional2006-05-31Completed
A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures[NCT00042081]Phase 33,000 participants Interventional2002-07-31Completed
Is There A LIfe for DES After Discontinuation of Clopidogrel:The ITALIC PLUS Trial[NCT01476020]1,240 participants (Anticipated)Observational2011-11-30Not yet recruiting
Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study[NCT01385319]Phase 31,606 participants (Actual)Interventional2011-06-30Active, not recruiting
CAOCT Study is a Prospective, Multi-centre, Single Cohort, Diagnostic Accuracy Study, Planned to Include 131 Patients in About 3 European Countries After Successful Return of Spontaneous Circulation After Out of Hospital Cardiac Arrest[NCT04431661]28 participants (Actual)Observational2021-01-29Terminated (stopped due to Low patient recruitment rate and change of hopsital procedures for handling cardiac arrest patients during emergency)
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents[NCT00638794]8,575 participants (Actual)Observational2008-01-31Completed
Dual Arm Factorial Randomized Trial in Patients w/ST Segment Elevation AMI to Compare the Results of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; and Primary An[NCT00433966]Phase 33,602 participants (Actual)Interventional2005-03-31Completed
The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery[NCT01707459]201 participants (Actual)Observational2010-03-31Completed
Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation[NCT02247128]Phase 41,016 participants (Actual)Interventional2014-01-31Completed
The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events[NCT05733208]766 participants (Anticipated)Interventional2023-05-06Recruiting
Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study[NCT04852406]526 participants (Anticipated)Interventional2021-04-21Recruiting
Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)[NCT00086450]Phase 31,900 participants (Actual)Interventional2004-04-30Active, not recruiting
Prospective Study of Bioresorbable Vascular Scaffold Treatment With Scoring Balloon Pre-dilatation in Patients With In-stent Restenosis[NCT03069066]Phase 4100 participants (Anticipated)Interventional2016-01-31Recruiting
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial[NCT01239953]Phase 4190 participants (Actual)Interventional2010-01-31Active, not recruiting
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial[NCT01239940]Phase 4310 participants (Anticipated)Interventional2010-01-31Recruiting
Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis[NCT02672878]Phase 4130 participants (Anticipated)Interventional2014-04-30Not yet recruiting
Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis[NCT03167424]100 participants (Anticipated)Observational [Patient Registry]2016-05-31Recruiting
Do Point-of-care Platelet Function Assays Predict Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI. (The POPular Study)[NCT00352014]1,000 participants (Anticipated)Observational2006-01-31Completed
Effect of Low Dose of Colchicine on Platelet Reactivty in Patients With Chronic Coronary Disease[NCT05956145]Phase 380 participants (Anticipated)Interventional2021-06-17Recruiting
Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374]Phase 4300 participants (Anticipated)Interventional2015-05-31Recruiting
Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention[NCT03114995]Phase 4140 participants (Actual)Interventional2012-02-01Completed
Influence of CILostazol-based Triple Anti-platelet Therapy ON Ischemic Complication After Drug-eluting stenT Implantation[NCT00776828]Phase 4960 participants (Actual)Interventional2006-11-30Completed
A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention[NCT03378934]Phase 464 participants (Anticipated)Interventional2018-09-26Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism [NCT00201461]Phase 2/Phase 3900 participants (Anticipated)Interventional2003-06-30Active, not recruiting
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding.[NCT02875353]235 participants (Anticipated)Interventional2017-02-15Recruiting
SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT00697372]Phase 4150 participants (Actual)Interventional2007-09-30Completed
Prospective Randomized Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions / BABILON Study (Paclitaxel-Coated Balloon in Bifurcated Lesions)[NCT01278186]Phase 4190 participants (Anticipated)Interventional2010-06-30Active, not recruiting
Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions[NCT00288535]Phase 4200 participants (Anticipated)Interventional2005-03-31Recruiting
Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation[NCT00905671]Phase 420 participants (Actual)Interventional2009-06-30Completed
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT01200693]Phase 480 participants (Actual)Interventional2008-11-30Completed
Approaches to Chronic Occlusions With Sirolimus Stents-Cypher (ACROSS-Cypher) Total Occlusion Study of Coronary Arteries 4 Trial[NCT00378612]Phase 3200 participants (Actual)Interventional2005-06-30Completed
Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery[NCT03445273]1,800 participants (Anticipated)Observational [Patient Registry]2018-11-21Not yet recruiting
Non-randomized, Open-label, Historical Control, Single Group Assignment Trial of a Reduced Dose of Unfractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions[NCT00735280]Phase 42,505 participants (Actual)Interventional2008-08-31Completed
Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting[NCT00776633]Phase 4614 participants (Actual)Interventional2008-09-30Active, not recruiting
Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.[NCT00149591]300 participants Interventional2001-04-30Active, not recruiting
A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percuta[NCT00271401]Phase 32,399 participants (Actual)Interventional1996-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Incidence of Major Adverse Coronary Events Within One Year Following Surgery

(NCT00228423)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
75mg Clopidogrel4
Placebo5

Incidence of Major Bleeding Events Within One Year Following Surgery

(NCT00228423)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
75mg Clopidogrel1
Placebo0

Vein Graft Angiographic Patency

Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery

Interventionpercentage (Number)
75mg Clopidogrel94.3
Placebo93.2

Vein Graft Intimal Area

IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery

Interventionmm (Mean)
75mg Clopidogrel4.1
Placebo4.5

Pharmacology Arm - Major Adverse Cardiovascular Events

Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) (NCT00433966)
Timeframe: 3 years

InterventionParticipants (Count of Participants)
Pharmacology Arm - Bivalirudin379
Pharmacology Arm - Unfractionated Heparin377

Pharmacology Arm - Major Adverse Cardiovascular Events

Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) (NCT00433966)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Pharmacology Arm - Bivalirudin98
Pharmacology Arm - Unfractionated Heparin99

Pharmacology Arm - Major Adverse Ischemic Cardiac Events and Major Bleeding Events

Number of participants with major adverse cardiovascular events (death, reinfarction, target-vessel revascularization for ischemia, and stroke) and major bleeding (bleeding adjudicated as not related to coronary artery bypass grafting). (NCT00433966)
Timeframe: 30 Days

InterventionParticipants (Count of Participants)
Pharmacology Arm - Bivalirudin166
Pharmacology Arm - Unfractionated Heparin218

Pharmacology Arm - Non-Coronary Artery Bypass Grafting-Related Major Bleeding

Number of participants with major bleeding (bleeding adjudicated as not related to coronary artery bypass grafting) (NCT00433966)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Pharmacology Arm - Bivalirudin89
Pharmacology Arm - Unfractionated Heparin149

Stent Arm - Death, Reinfarction, Stroke, or Stent Thrombosis

Number of Participants With Death, Reinfarction, Stroke, or Stent Thrombosis (NCT00433966)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
Stent Arm - Paclitaxel-Eluting Stent181
Stent Arm - Bare Metal Stent59

Stent Arm - Ischemic Target Lesion Revascularization

Number of Participants With Ischemic Target Lesion Revascularization (NCT00433966)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
Stent Arm - Paclitaxel-Eluting Stent98
Stent Arm - Bare Metal Stent54

Stent Arm - Segment Binary Angiographic Restenosis

Number of Participants With Segment Binary Angiographic Restenosis (13-month Angiographic Subset). (NCT00433966)
Timeframe: 13 months

InterventionParticipants (Count of Participants)
Stent Arm - Paclitaxel-Eluting Stent102
Stent Arm - Bare Metal Stent76

5-year Composite Endpoint of All-cause Mortality, Non-fatal Myocardial Infarction, and Stroke

median 3.8 years of follow-up (NCT00086450)
Timeframe: Measured at Year 5

Interventionpercentage of participants (Number)
Percutaneous Coronary Intervention26.6
Coronary Artery Bypass Graft18.7

All-cause Mortality

(NCT00086450)
Timeframe: Measured at Year 5

Interventionpercentage of participants (Number)
Percutaneous Coronary Intervention16.3
Coronary Artery Bypass Graft10.9

Major MACCE Rates, Including the First of One of the Following: Death, Myocardial Infarction, Stroke, or Repeat Revascularization

(NCT00086450)
Timeframe: Measured at Year 1

Interventionpercentage of participants (Number)
Percutaneous Coronary Intervention16.8
Coronary Artery Bypass Graft11.8

Rates of Individual MACCE Endpoints

Major adverse cardiovascular and cerebrovascular events (NCT00086450)
Timeframe: Measured at Day 30

Interventionpercentage of participants (Number)
Percutaneous Coronary Intervention4.8
Coronary Artery Bypass Graft5.2

Area Under Curve of Serial Cardiac Biomarkers

An area under the curve of serial levels of Troponin I and creatine kinase-MB isoenzyme during 36 hours (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours

,,
InterventionHours*ng/ml (Median)
Troponin Icreatine kinase-MB isoenzyme
Control C1 (High Platelet Reactivity - no Tirofiban)38.092.7
Control C2 (Low Platelet Reactivity - no Tirofiban)121.4185.6
Group A (High Platelet Reactivity - Tirofiban)197.2252.5

Percentage of Participants With Periprocedural Myonecrosis

"Percentage of participants with periprocedural myonecrosis under the criteria described below.~When the cardiac biomarkers before the procedure were within the 99th percentile upper reference limit (URL), more than a 5-fold elevation in the URL within 12 hours after percutaneous coronary intervention (PCI) was defined as periprocedural myonecrosis. If the cardiac biomarker level was already above the 99th percentile URL before the procedure and the trend was stationary or decreasing, a ≥20% increase compared to the previous level was considered periprocedural myonecrosis. If the trend was still increasing, the levels at the post-6 hour and 12-hour were compared to determine periprocedural myonecrosis." (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours

,,
InterventionParticipants (Count of Participants)
Troponin Icreatine kinase-MB isoenzyme
Control C1 (High Platelet Reactivity - no Tirofiban)1510
Control C2 (Low Platelet Reactivity - no Tirofiban)2625
Group A (High Platelet Reactivity - Tirofiban)1611

Reviews

32 reviews available for ticlopidine and Postoperative Complications

ArticleYear
Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients.
    Seminars in thrombosis and hemostasis, 2017, Volume: 43, Issue:7

    Topics: Aspirin; Blood Platelets; Cardiac Surgical Procedures; Hemorrhage; Humans; Platelet Aggregation Inhi

2017
Triple therapy: worth the risk?
    Minerva medica, 2018, Volume: 109, Issue:5

    Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitor

2018
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
    Journal of thrombosis and thrombolysis, 2013, Volume: 35, Issue:4

    Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Fibrinolytic Agents; Heart Val

2013
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Journal of cardiac surgery, 2013, Volume: 28, Issue:2

    Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occl

2013
Diagnosis and management of carotid atherosclerosis.
    BMJ (Clinical research ed.), 2013, Mar-18, Volume: 346

    Topics: Carotid Artery Diseases; Carotid Artery, Common; Clopidogrel; Endarterectomy, Carotid; Female; Human

2013
Perioperative management of anticoagulation in elective surgery.
    ANZ journal of surgery, 2013, Volume: 83, Issue:11

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Di

2013
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2013, Volume: 13, Issue:5

    Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combi

2013
Aspirin, clopidogrel, and the surgeon.
    Advances in surgery, 2014, Volume: 48

    Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Humans; Platelet Aggregati

2014
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
    The Canadian journal of cardiology, 2015, Volume: 31, Issue:6

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Fem

2015
Perioperative Management to Reduce Cardiovascular Events.
    Circulation, 2016, Mar-15, Volume: 133, Issue:11

    Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspi

2016
Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy.
    International journal of cardiology, 2017, Feb-15, Volume: 229

    Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Percutaneous Coronary Intervention; Platelet Aggregati

2017
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
    Expert opinion on drug safety, 2009, Volume: 8, Issue:2

    Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combinatio

2009
Clopidogrel before elective percutaneous coronary intervention.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Elective Surgical Procedures;

2010
[Perioperative antiplatelet therapy of patients with coronary stents].
    Praxis, 2009, Oct-21, Volume: 98, Issue:21

    Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort S

2009
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.
    Journal of the American College of Cardiology, 2010, Nov-02, Volume: 56, Issue:19

    Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Postoperative Complica

2010
Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:6

    Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Blood Vessel Prosthesis Implantation; Clopid

2011
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies.
    European heart journal, 2011, Volume: 32, Issue:23

    Topics: Acute Coronary Syndrome; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critical Care; Fema

2011
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.
    Journal of the American College of Cardiology, 2011, Nov-01, Volume: 58, Issue:19

    Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Inf

2011
Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Hospital practice (1995), 2012, Volume: 40, Issue:2

    Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel

2012
[Platelet function: new drugs, new assays : possible impacts on operative medicine?].
    Der Anaesthesist, 2012, Volume: 61, Issue:6

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Piperazines; Platelet Aggregation; P

2012
Clopidogrel: the data, the experience, and the controversies.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2012, Dec-01, Volume: 12, Issue:6

    Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; H

2012
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?].
    Zentralblatt fur Chirurgie, 2012, Volume: 137, Issue:5

    Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relations

2012
State of the art--a journey through the world of antithrombotic therapy.
    Seminars in thrombosis and hemostasis, 2002, Volume: 28 Suppl 3

    Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A

2002
[Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:9

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative

2003
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6

    Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost

2005
[Very late intrastent thrombosis--at 27 months!].
    Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:3

    Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Fatal Outcome; Flurbiprofen; Follow-Up Studies; Hernia, I

2007
Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
    Interactive cardiovascular and thoracic surgery, 2007, Volume: 6, Issue:4

    Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicin

2007
Con: continuation of aspirin/clopidogrel for cardiac surgery.
    Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:4

    Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans

2007
Pro: continuation of aspirin/clopidogrel for cardiac surgery.
    Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:4

    Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhi

2007
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
    The American journal of cardiology, 2007, Oct-15, Volume: 100, Issue:8

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedul

2007
Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
    Journal of thrombosis and thrombolysis, 2000, Volume: 9, Issue:2

    Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass;

2000
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Circulation, 1986, Volume: 73, Issue:2

    Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical

1986

Trials

70 trials available for ticlopidine and Postoperative Complications

ArticleYear
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice
    American heart journal, 2021, Volume: 236

    Topics: Acute Coronary Syndrome; Adult; Aspirin; Coronary Angiography; Drug-Eluting Stents; Dual Anti-Platel

2021
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2017, Sep-01, Volume: 52, Issue:3

    Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, D

2017
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
    American heart journal, 2017, Volume: 188

    Topics: Adenosine Monophosphate; Administration, Oral; Aged; Cause of Death; Clopidogrel; Coronary Angiograp

2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).
    The American journal of cardiology, 2017, Oct-01, Volume: 120, Issue:7

    Topics: Adenosine Monophosphate; Aged; Anticoagulants; Clopidogrel; Dose-Response Relationship, Drug; Double

2017
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.
    Scientific reports, 2018, 01-19, Volume: 8, Issue:1

    Topics: Aged; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Cytochrome

2018
Anterior chamber bleeding after laser peripheral iridotomy.
    JAMA ophthalmology, 2013, Volume: 131, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; F

2013
Combination of high on-treatment platelet aggregation and low deaggregation better predicts long-term cardiovascular events in PCI patients under dual antiplatelet therapy.
    Platelets, 2014, Volume: 25, Issue:6

    Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Disease-Free Surviva

2014
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
    Journal of the American College of Cardiology, 2014, Feb-18, Volume: 63, Issue:6

    Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Restenosis; Female; Humans; Italy; Male; Mid

2014
Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
    The American journal of cardiology, 2014, May-15, Volume: 113, Issue:10

    Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Croatia; Dose-Response

2014
A high ratio of ADP-TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:12

    Topics: Adenosine Diphosphate; Aged; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Humans; Ma

2014
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
    Circulation, 2014, Oct-21, Volume: 130, Issue:17

    Topics: Aged; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Gra

2014
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:12

    Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP

2014
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
    Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8

    Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Elu

2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
    Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8

    Topics: Aged; Aged, 80 and over; Aspirin; Biocompatible Materials; Clopidogrel; Coronary Angiography; Corona

2015
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
    European heart journal. Acute cardiovascular care, 2017, Volume: 6, Issue:7

    Topics: Aged; Antithrombins; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combinati

2017
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
    Circulation. Cardiovascular interventions, 2015, Volume: 8, Issue:10

    Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up Studies; Humans;

2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
    Circulation. Cardiovascular interventions, 2015, Volume: 8, Issue:10

    Topics: Aged; Blood Vessel Prosthesis Implantation; Clopidogrel; Drug Interactions; Drug-Eluting Stents; Fem

2015
Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:23

    Topics: Adenosine; Aged; Clopidogrel; Combined Modality Therapy; Drug Administration Schedule; Female; Human

2015
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.
    British journal of anaesthesia, 2016, Volume: 116, Issue:4

    Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans;

2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
    American heart journal, 2016, Volume: 173

    Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug;

2016
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2016, Volume: 87, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi

2016
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.
    Medicine, 2016, Volume: 95, Issue:22

    Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography;

2016
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, May-15, Volume: 13, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Drug Therapy, Combination; Female

2017
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
    Neurological research, 2017, Volume: 39, Issue:8

    Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati

2017
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.
    International journal of cardiology, 2009, May-29, Volume: 134, Issue:3

    Topics: Aged; Cardiovascular Surgical Procedures; Clopidogrel; Drug Resistance; Drug Therapy, Combination; D

2009
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20

    Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis;

2008
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    The Annals of thoracic surgery, 2009, Volume: 88, Issue:1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Re

2009
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:2

    Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
    JAMA, 2010, Feb-24, Volume: 303, Issue:8

    Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction

2010
The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applyin
    American heart journal, 2010, Volume: 160, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Echocardiography, Stress; Humans; Myo

2010
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
    Journal of the American College of Cardiology, 2011, Jan-18, Volume: 57, Issue:3

    Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination;

2011
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
    Journal of the American College of Cardiology, 2011, Jan-18, Volume: 57, Issue:3

    Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination;

2011
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
    Journal of the American College of Cardiology, 2011, Jan-18, Volume: 57, Issue:3

    Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination;

2011
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
    Journal of the American College of Cardiology, 2011, Jan-18, Volume: 57, Issue:3

    Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination;

2011
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
    The New England journal of medicine, 2012, Mar-15, Volume: 366, Issue:11

    Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Co

2012
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
    International journal of cardiology, 2013, Aug-20, Volume: 167, Issue:4

    Topics: Aged; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; P

2013
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYo
    International journal of cardiology, 2012, Oct-18, Volume: 160, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Dose-Response Relationship, Drug; Humans; International

2012
Angioplasty and stent treatment of transplant renal artery stenosis.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, Jul-17, Volume: 32, Issue:4

    Topics: Adult; Aged; Angioplasty; Anticoagulants; Aspirin; Clopidogrel; Female; Follow-Up Studies; Humans; H

2012
[A prospective randomized control clinical trial about clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after femoral-popliteal artery angioplasty].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2012, Volume: 50, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Clopidogrel; Fema

2012
Effect of antioxidant probucol for preventing stent restenosis.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 57, Issue:4

    Topics: Aged; Antioxidants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Ar

2002
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
    Journal of the American College of Cardiology, 2003, Mar-19, Volume: 41, Issue:6

    Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Drug Ther

2003
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Circulation, 2004, Mar-16, Volume: 109, Issue:10

    Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity;

2004
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
    Circulation, 2004, Mar-30, Volume: 109, Issue:12

    Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endar

2004
Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    Journal of the American College of Cardiology, 2004, Jul-07, Volume: 44, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel;

2004
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Journal of the American College of Cardiology, 2004, Sep-15, Volume: 44, Issue:6

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Combined Modal

2004
Magnetic Vascular Port in minimally invasive direct coronary artery bypass grafting.
    Circulation, 2004, Sep-14, Volume: 110, Issue:11 Suppl 1

    Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Angiography; Drug Therapy, Combination; Equipment

2004
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6

    Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost

2005
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
    Journal of the American College of Cardiology, 2005, May-03, Volume: 45, Issue:9

    Topics: Adenosine Diphosphate; Aged; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Femal

2005
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.
    Journal of the American College of Cardiology, 2006, Mar-07, Volume: 47, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Ischemia;

2006
Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Contrast Media; Coronary Angio

2006
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight.
    Stroke, 2007, Volume: 38, Issue:9

    Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Body Weight; Clopidogrel; Endarterectomy, Carotid;

2007
Ticlopidine and coronary surgery.
    Agents and actions. Supplements, 1984, Volume: 15

    Topics: Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Humans; Post

1984
The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.
    The Journal of international medical research, 1981, Volume: 9, Issue:3

    Topics: Bleeding Time; Hemorrhage; Humans; Male; Platelet Function Tests; Postoperative Complications; Prost

1981
[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
    La Nouvelle presse medicale, 1980, Nov-15, Volume: 9, Issue:43

    Topics: Adolescent; Adult; Aged; Blood Coagulation; Cardiac Surgical Procedures; Extracorporeal Circulation;

1980
Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation.
    Coronary artery disease, 1995, Volume: 6, Issue:4

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Drug Therapy, Combination; Female;

1995
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi

1996
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi

1996
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi

1996
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi

1996
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy.
    Circulation, 1997, Mar-04, Volume: 95, Issue:5

    Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Eq

1997
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISA
    Circulation, 1997, Apr-15, Volume: 95, Issue:8

    Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Diseases; Combined Modality

1997
PAMI (Primary Angioplasty in Myocardial Infarction) Stent Pilot Trial.
    Clinical cardiology, 1998, Volume: 21, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Drug Therapy, Combination; Follow-Up Studies; Humans; Myoca

1998
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
    Lancet (London, England), 1998, Jul-11, Volume: 352, Issue:9122

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona

1998
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
    Lancet (London, England), 1998, Jul-11, Volume: 352, Issue:9122

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona

1998
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
    Lancet (London, England), 1998, Jul-11, Volume: 352, Issue:9122

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona

1998
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
    Lancet (London, England), 1998, Jul-11, Volume: 352, Issue:9122

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona

1998
Low molecular weight heparin in coronary stenting.
    The Canadian journal of cardiology, 1998, Volume: 14 Suppl E

    Topics: Coronary Disease; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pilot Proj

1998
Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    The Journal of heart valve disease, 1998, Volume: 7, Issue:6

    Topics: Aortic Valve; Bioprosthesis; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Huma

1998
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
    Circulation, 1999, May-11, Volume: 99, Issue:18

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; D

1999
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
    Circulation, 2000, Feb-15, Volume: 101, Issue:6

    Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Female

2000
[The drug prevention of postoperative thromboses in patients with critical lower limb ischemia].
    Likars'ka sprava, 1999, Issue:5

    Topics: Anticoagulants; Aspirin; Critical Illness; Humans; Ischemia; Leg; Nadroparin; Platelet Aggregation I

1999
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
    American heart journal, 2000, Volume: 140, Issue:3

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Thrombosis; Drug T

2000
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
    Circulation, 2001, Jan-23, Volume: 103, Issue:3

    Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Female; Hospitalization; Hum

2001
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial.
    Circulation, 2001, Mar-13, Volume: 103, Issue:10

    Topics: Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Models, Statistical; Outcome and Process

2001
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
    Circulation, 2001, Apr-24, Volume: 103, Issue:16

    Topics: Administration, Oral; Aneurysm, False; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cere

2001
Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 55, Issue:2

    Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Carbon; Coa

2002
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Circulation, 1986, Volume: 73, Issue:2

    Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical

1986
Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion.
    European heart journal, 1985, Volume: 6, Issue:2

    Topics: Acenocoumarol; Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypas

1985
Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.
    Scandinavian journal of urology and nephrology, 1985, Volume: 19, Issue:1

    Topics: Adult; Aged; Anticoagulants; Arteriovenous Shunt, Surgical; Clinical Trials as Topic; Double-Blind M

1985

Other Studies

213 other studies available for ticlopidine and Postoperative Complications

ArticleYear
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2020, Jan-17, Volume: 15, Issue:13

    Topics: Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibito

2020
Administration of Ticagrelor and Double-Dose Clopidogrel Based on Platelet Reactivity Determined by VerifyNow-P2Y12 for Chinese Subjects After Elective PCI.
    International heart journal, 2017, Apr-06, Volume: 58, Issue:2

    Topics: Adenosine; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutane

2017
A retrospective comparison between delayed and early hip fracture surgery in patients taking clopidogrel: same total bleeding but different timing of blood transfusion.
    International orthopaedics, 2017, Volume: 41, Issue:9

    Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Female; Fracture Fixation, Internal; Hemiar

2017
Poor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort study.
    Medicine, 2017, Volume: 96, Issue:39

    Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; China; Clopidogrel; Cohort S

2017
Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy.
    American journal of surgery, 2017, Volume: 214, Issue:6

    Topics: Adult; Appendectomy; Appendicitis; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Fe

2017
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.
    The Annals of thoracic surgery, 2017, Volume: 104, Issue:6

    Topics: Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Huma

2017
Unplanned readmission following transoral robotic surgery.
    Oral oncology, 2017, Volume: 75

    Topics: Carcinoma, Squamous Cell; Clopidogrel; Dehydration; Female; Humans; Male; Middle Aged; Mouth; Mouth

2017
Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
    International heart journal, 2018, Jan-27, Volume: 59, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Dose-Response Relationshi

2018
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
    The Annals of thoracic surgery, 2018, Volume: 105, Issue:2

    Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist

2018
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2018, Volume: 46, Issue:5

    Topics: Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Femal

2018
Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
    Heart and vessels, 2019, Volume: 34, Issue:6

    Topics: Aged; Aged, 80 and over; Aspirin; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug-Eluting St

2019
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:9

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defib

2013
Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2013, Volume: 14, Issue:3

    Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Comorbidity; Databases, Factual; Female; He

2013
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Journal of the American College of Cardiology, 2013, Sep-10, Volume: 62, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopido

2013
Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
    Journal of cardiac surgery, 2013, Volume: 28, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Corona

2013
Clopidogrel reduces post-transplant obliterative bronchiolitis.
    Transplant international : official journal of the European Society for Organ Transplantation, 2013, Volume: 26, Issue:10

    Topics: Animals; Blood Platelets; Bronchiolitis Obliterans; Calcineurin Inhibitors; Clopidogrel; Cytokines;

2013
A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching.
    Journal of interventional cardiology, 2013, Volume: 26, Issue:5

    Topics: Angioplasty; Antithrombins; Clopidogrel; Cohort Studies; Drug Combinations; Female; Hirudins; Humans

2013
Is it possible? Predicting complications and morbidity in surgical patients on clopidogrel therapy with Thrombelastography Platelet Mapping.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2014, Volume: 15, Issue:1

    Topics: Female; Hemorrhage; Hip Fractures; Humans; Male; Postoperative Complications; Ticlopidine

2014
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.
    Circulation. Cardiovascular quality and outcomes, 2013, Volume: 6, Issue:6

    Topics: Acute Coronary Syndrome; Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogre

2013
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:2

    Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug;

2014
Thromboelastography platelet mapping for surgical patients: lessons from cardiac surgery.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2014, Volume: 15, Issue:1

    Topics: Female; Hemorrhage; Hip Fractures; Humans; Male; Postoperative Complications; Ticlopidine

2014
Reply to Rubino et al.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2014, Volume: 46, Issue:2

    Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I

2014
Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2014, Volume: 46, Issue:2

    Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I

2014
A cautionary tale on the use of antiplatelet treatment following TURP.
    BMJ case reports, 2014, Apr-04, Volume: 2014

    Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myoca

2014
The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:7

    Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neur

2014
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy.
    BMJ case reports, 2014, Jul-15, Volume: 2014

    Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Elu

2014
Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery.
    The British journal of surgery, 2014, Volume: 101, Issue:11

    Topics: Aged; Case-Control Studies; Clopidogrel; Erythrocyte Transfusion; Female; Humans; Male; Middle Aged;

2014
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
    Circulation. Cardiovascular interventions, 2014, Volume: 7, Issue:4

    Topics: Acute Disease; Age Factors; Aged; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged;

2014
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
    World journal of urology, 2015, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascula

2015
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C

2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C

2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C

2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C

2014
Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2015, Volume: 16, Issue:3

    Topics: Adult; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Female; Humans; Italy; Longitudinal Stud

2015
Should clopidogrel be discontinued before laparoscopic cholecystectomy?
    American journal of surgery, 2014, Volume: 208, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Cholecystectomy, Laparoscopic; Clopidogrel; Fe

2014
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
    American heart journal, 2015, Volume: 169, Issue:2

    Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Decision Support Techniques; Drug-Eluting Stents; Fem

2015
Stent selection and antiplatelet therapy duration: one size does not fit all.
    Journal of the American College of Cardiology, 2015, Mar-03, Volume: 65, Issue:8

    Topics: Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage;

2015
Optimal antiplatelet therapy in out-hospital cardiac arrest patients treated by primary percutaneous coronary intervention.
    Resuscitation, 2015, Volume: 90

    Topics: Female; Heart Arrest; Humans; Hypothermia, Induced; Male; Myocardial Infarction; Percutaneous Corona

2015
Effects of anticoagulants on outcome of femoral neck fracture surgery.
    Journal of orthopaedic surgery (Hong Kong), 2015, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Human

2015
Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series.
    Journal of surgical orthopaedic advances, 2015,Summer, Volume: 24, Issue:2

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Clopidogre

2015
Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Internal medicine journal, 2015, Volume: 45, Issue:10

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Australia; Clopidogrel; Female; Hemorrhage; Humans; Logistic

2015
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
    Journal of endourology, 2015, Volume: 29, Issue:11

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogre

2015
[The ISAR-SAFE study].
    Giornale italiano di cardiologia (2006), 2015, Volume: 16, Issue:6

    Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Administr

2015
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
    Atherosclerosis, 2015, Volume: 242, Issue:1

    Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-4

2015
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
    Thrombosis and haemostasis, 2015, Volume: 114, Issue:5

    Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrin

2015
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up.
    Cardiology, 2015, Volume: 132, Issue:3

    Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Angiograp

2015
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
    Neurological research, 2015, Volume: 37, Issue:11

    Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures;

2015
Revisiting the Clopidogrel-Proton Pump Inhibitor Interaction: From Bench to Bedside.
    Circulation. Cardiovascular interventions, 2015, Volume: 8, Issue:10

    Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl

2015
Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Cardiovascular intervention and therapeutics, 2017, Volume: 32, Issue:1

    Topics: Absorbable Implants; Adult; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Coronary Vessels

2017
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.
    Medicine, 2015, Volume: 94, Issue:46

    Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Evero

2015
Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
    Journal of neurosurgery, 2016, Volume: 125, Issue:2

    Topics: Adult; Aged; Aspirin; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Mid

2016
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2016, Volume: 154, Issue:3

    Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hem

2016
Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.
    The Annals of thoracic surgery, 2016, Volume: 101, Issue:2

    Topics: Aspirin; Clopidogrel; Hemoptysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumo

2016
Decision making on timing of surgery for hip fracture patients on clopidogrel.
    Annals of the Royal College of Surgeons of England, 2016, Volume: 98, Issue:2

    Topics: Aged, 80 and over; Blood Transfusion; Clopidogrel; Contraindications; Decision Making; Female; Hemog

2016
Letter by Pacheco et al Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".
    Circulation. Cardiovascular interventions, 2016, Volume: 9, Issue:3

    Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl

2016
Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".
    Circulation. Cardiovascular interventions, 2016, Volume: 9, Issue:3

    Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Female; Humans; Male; Postoperative Compl

2016
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
    International heart journal, 2016, Volume: 57, Issue:2

    Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up S

2016
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.
    Annals of surgical oncology, 2016, Volume: 23, Issue:9

    Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Hematoma; Humans; Male; Middle Aged; Parathyroidectomy

2016
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Mar-01, Volume: 89, Issue:4

    Topics: Acute Coronary Syndrome; Age Factors; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Stud

2017
Complication of Stenting in Intracranial Arterial Stenosis.
    Archives of Iranian medicine, 2016, Volume: 19, Issue:5

    Topics: Age Factors; Aged; Angioplasty; Aspirin; China; Clopidogrel; Computed Tomography Angiography; Constr

2016
Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: Adenosine; Aged; Aspirin; Blood Coagulation; Cardiomyopathies; Clopidogrel; Drug Substitution; Drug

2016
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response.
    Journal of neurointerventional surgery, 2017, Volume: 9, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Cohort Studies; Elective Surgical Procedures; Endovascu

2017
The Effect of Antiplatelet Agents on Bleeding-Related Complications After Ureteroscopy.
    Journal of endourology, 2016, Volume: 30, Issue:10

    Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Hemorrhage; H

2016
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
    Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:6

    Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopid

2016
Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate.
    Brazilian journal of cardiovascular surgery, 2016, Volume: 31, Issue:2

    Topics: Aspirin; Cardiopulmonary Bypass; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Fem

2016
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
    Journal of the American College of Cardiology, 2016, 10-25, Volume: 68, Issue:17

    Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle A

2016
Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy.
    Urology, 2017, Volume: 99

    Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug;

2017
Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2017, Volume: 23, Issue:1

    Topics: Adult; Aged; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolizatio

2017
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.
    Scientific reports, 2016, 10-21, Volume: 6

    Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Graft Survival; Heparin;

2016
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    Journal of the American College of Cardiology, 2017, Jan-17, Volume: 69, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Cause of Death; Clopidogrel; Diabetic Angiopathies; Drug The

2017
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
    Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:1

    Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequenc

2017
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
    Journal of cardiac surgery, 2017, Volume: 32, Issue:3

    Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Va

2017
Clopidogrel therapy--implications for hip fracture surgery.
    Injury, 2008, Volume: 39, Issue:10

    Topics: Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Drug Administration Schedule; Follow-Up Studie

2008
Very late stent thrombosis after discontinuation of clopidogrel therapy.
    The Medical journal of Australia, 2008, Aug-18, Volume: 189, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studi

2008
Survival benefit with concomitant oral platelet therapy after coronary angiography and before ad hoc percutaneous coronary intervention.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography;

2008
Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Confidence Intervals;

2008
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
    The Journal of thoracic and cardiovascular surgery, 2008, Volume: 136, Issue:4

    Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Anim

2008
[Management of a high risk of thrombosis patient with drug-eluting stents undergoing a complete gastrectomy].
    Annales francaises d'anesthesie et de reanimation, 2009, Volume: 28, Issue:1

    Topics: Aged; Clopidogrel; Drug-Eluting Stents; Gastrectomy; Humans; Male; Monitoring, Physiologic; Platelet

2009
Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome.
    Revista espanola de cardiologia, 2009, Volume: 62, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronar

2009
[Do antiplatelet agents (aspirin and other antiplatelets such as clopidogrel) increase the risk of hemorrhagic complications after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these pro
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:4

    Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Hemorrhage; Humans; Platelet Aggregation Inhibito

2009
Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.
    JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:1

    Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosi

2008
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
    Tennessee medicine : journal of the Tennessee Medical Association, 2009, Volume: 102, Issue:5

    Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusio

2009
[Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2010, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopid

2010
Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes.
    Stroke, 2009, Volume: 40, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Cerebral Arteries; Clopidogrel; Fema

2009
Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome.
    Journal of medical economics, 2009, Volume: 12, Issue:4

    Topics: Acute Coronary Syndrome; Aged; American Heart Association; Blood Transfusion; Clopidogrel; Coronary

2009
Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
    The Journal of thoracic and cardiovascular surgery, 2009, Volume: 138, Issue:6

    Topics: Adult; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Female; Human

2009
[Antiplatelet therapy and urgent surgical procedures. Acute appendicitis two days after stent implantation--a case report].
    Kardiologia polska, 2009, Volume: 67, Issue:12

    Topics: Appendicitis; Clopidogrel; Coronary Thrombosis; Dobutamine; Humans; Intraoperative Complications; Ma

2009
Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.
    Interactive cardiovascular and thoracic surgery, 2010, Volume: 10, Issue:5

    Topics: Analysis of Variance; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Cor

2010
Safety of carotid endarterectomy while on clopidogrel (Plavix). Clinical article.
    Journal of neurosurgery, 2010, Volume: 113, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Edema; E

2010
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
    The American surgeon, 2010, Volume: 76, Issue:1

    Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures;

2010
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
    British journal of anaesthesia, 2010, Volume: 104, Issue:4

    Topics: Aged; Analgesia, Epidural; Clopidogrel; Female; Hematoma, Epidural, Spinal; Humans; Male; Middle Age

2010
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
    Circulation, 2010, Mar-09, Volume: 121, Issue:9

    Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug

2010
[Comment about patients with dual antiplatelet therapy].
    Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:2

    Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Contraindications; Drug Therapy, Combina

2010
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:5

    Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platel

2010
I had two stents put in during the past year, but I'm going to have a hip replacement soon. Are there any heart-related or stent related precautions my doctor and I should take before the surgery?
    Heart advisor, 2009, Volume: 12, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Arthroplasty, Replacement, Hip; Aspirin; Clopidogrel; Drug-Eluting S

2009
Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.
    Circulation. Cardiovascular quality and outcomes, 2010, Volume: 3, Issue:3

    Topics: Cardiovascular Diseases; Chemotherapy, Adjuvant; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up

2010
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
    Minerva cardioangiologica, 2010, Volume: 58, Issue:2

    Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Chemical and Drug Induced Liver Injury; Clopidogr

2010
Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2010, Volume: 40, Issue:2

    Topics: Aged; Angioscopy; Anticoagulants; Aspirin; Clopidogrel; Dextrans; Drug Therapy, Combination; Endarte

2010
The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery.
    Journal of orthopaedic trauma, 2010, Volume: 24, Issue:6

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Contraindications; Femal

2010
Clinical pharmacology: antiplatelet therapy during surgery.
    Heart (British Cardiac Society), 2010, Volume: 96, Issue:12

    Topics: Aspirin; Blood Loss, Surgical; Clopidogrel; Humans; Perioperative Care; Platelet Aggregation Inhibit

2010
The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention.
    Circulation. Cardiovascular interventions, 2010, Jun-01, Volume: 3, Issue:3

    Topics: Acute Coronary Syndrome; Atherectomy; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Diagnostic

2010
Routine platelet testing should not be performed on all patients undergoing percutaneous coronary intervention.
    Circulation. Cardiovascular interventions, 2010, Jun-01, Volume: 3, Issue:3

    Topics: Acute Coronary Syndrome; Atherectomy; Blood Platelets; Clopidogrel; Diagnostic Tests, Routine; Human

2010
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
    British journal of anaesthesia, 2010, Volume: 105, Issue:2

    Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitor

2010
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
    British journal of anaesthesia, 2010, Volume: 105, Issue:2

    Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitor

2010
Frequency and risk of noncardiac surgery after drug-eluting stent implantation.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jun-01, Volume: 77, Issue:7

    Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Drug-Eluting Stents; Fem

2011
Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?
    Neurosurgery, 2010, Volume: 67, Issue:5

    Topics: Aneurysm, Ruptured; Clopidogrel; Embolization, Therapeutic; Female; Humans; Incidence; Intracranial

2010
Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
    Ophthalmology, 2011, Volume: 118, Issue:3

    Topics: Aged; Anticoagulants; Cardiovascular Diseases; Choroid Hemorrhage; Clopidogrel; Humans; Incidence; I

2011
Upper digestive bleeding due to Dieulafoy´s lesion during the postoperative period of aortocoronary bypass surgery in a patient treated with clopidogrel.
    Revista espanola de enfermedades digestivas, 2010, Volume: 102, Issue:11

    Topics: Aged; Arterioles; Clopidogrel; Coronary Artery Bypass; Gastrointestinal Hemorrhage; Humans; Male; Pl

2010
Invited commentary.
    The Annals of thoracic surgery, 2011, Volume: 91, Issue:2

    Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Drainage; Humans; Intubation

2011
Immortal person-time bias in observational studies in cardiac surgery.
    The Journal of thoracic and cardiovascular surgery, 2011, Volume: 141, Issue:3

    Topics: Aspirin; Bias; Clopidogrel; Coronary Artery Bypass; Data Interpretation, Statistical; Drug Therapy,

2011
Did clopidogrel confound the results?
    The Annals of thoracic surgery, 2011, Volume: 91, Issue:3

    Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Humans; Platelet Aggregation Inhibitors; Postoperativ

2011
Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
    The American journal of cardiology, 2011, Apr-01, Volume: 107, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Drug Resistance; Humans; Kidney Failur

2011
Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms.
    AJNR. American journal of neuroradiology, 2011, Volume: 32, Issue:4

    Topics: Adult; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Circulation; Clopidogrel; F

2011
[Preoperative analysis of platelet aggregability in carotid surgery].
    No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:5

    Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Clopidogrel; Endarterectomy, Carotid; Female; Hu

2011
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Fem

2011
The impact of noncardiac surgery on selection of a revascularization strategy.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jun-01, Volume: 77, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Drug-Eluting Stents; Humans; Myocardial Infarction; Pat

2011
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
    Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:8

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, C

2011
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:3

    Topics: Aged; Ambulatory Surgical Procedures; Antibiotic Prophylaxis; Anticoagulants; Clopidogrel; Dermatolo

2011
Emergency surgery following trancutaneous aortic valve insertion.
    Anaesthesia and intensive care, 2011, Volume: 39, Issue:4

    Topics: Aged, 80 and over; Aortic Valve; Aspirin; Blood Loss, Surgical; Clopidogrel; Emergency Medical Servi

2011
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:10

    Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperativ

2011
Clopidogrel: is a surgical delay necessary in fractured neck of femur?
    Annals of the Royal College of Surgeons of England, 2011, Volume: 93, Issue:4

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Dipyridamole; Female; Femoral Neck Fract

2011
Thrombus formation on a left atrial appendage closure device.
    Circulation, 2011, Oct-04, Volume: 124, Issue:14

    Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design;

2011
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
    Neuro-Chirurgie, 2012, Volume: 58, Issue:1

    Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hemat

2012
On-clopidogrel platelet reactivity: a target in sight?
    Journal of the American College of Cardiology, 2011, Nov-01, Volume: 58, Issue:19

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Platelet Activation; Platelet Agg

2011
The safety of major head and neck surgery in patients taking clopidogrel (Plavix).
    Plastic and reconstructive surgery, 2012, Volume: 129, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Thrombosis; Female; Head and Neck

2012
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:2

    Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion; Clopi

2012
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Heparin; Humans; Intra-Aortic

2012
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
    Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupi

2012
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
    Circulation. Cardiovascular interventions, 2012, Feb-01, Volume: 5, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cas

2012
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
    The American journal of cardiology, 2012, Jul-01, Volume: 110, Issue:1

    Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrilla

2012
Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Animals; Clinical Protocols; Clopidog

2012
Utility of VasoCT in the treatment of intracranial aneurysm with flow-diverter stents.
    Journal of neurosurgery, 2012, Volume: 117, Issue:1

    Topics: Adult; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Catheterization; Cereb

2012
To the editor.
    Journal of orthopaedic trauma, 2012, Volume: 26, Issue:6

    Topics: Female; Humans; Male; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complica

2012
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2013, Volume: 43, Issue:4

    Topics: Aged; Aspirin; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Fema

2013
Perioperative management of a neurosurgical patient requiring antiplatelet therapy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:9

    Topics: Aged; Aspirin; Cerebral Angiography; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Thromb

2012
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
    BMJ case reports, 2012, Sep-24, Volume: 2012

    Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage;

2012
Clopidogrel and aspirin administration management prior to coronary artery surgery requires an individual approach.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2013, Volume: 43, Issue:6

    Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I

2013
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
    Neurosurgery, 2013, Volume: 72, Issue:3

    Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Patholog

2013
Friend or foe? Discussion about dual platelet inhibition as a salvage procedure from imminent flap failure.
    Plastic and reconstructive surgery, 2013, Volume: 131, Issue:1

    Topics: Aspirin; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mamma

2013
Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section.
    BMJ case reports, 2013, Jan-24, Volume: 2013

    Topics: Aspirin; Cerebral Angiography; Cesarean Section; Clopidogrel; Female; Headache; Humans; Magnetic Res

2013
[Long-term anticoagulation after bypass operation].
    Der Internist, 2002, Volume: 43, Issue:8

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhi

2002
New antiplatelet agents and prosthetic heart valves.
    QJM : monthly journal of the Association of Physicians, 2002, Volume: 95, Issue:10

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Clopidogrel; Female; Heart Valve Prosthesis Implantation; H

2002
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:11

    Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem

2002
Clopidogrel versus ticlopidine after the placement of coronary artery stents.
    Journal of the American College of Cardiology, 2003, Aug-20, Volume: 42, Issue:4

    Topics: Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans

2003
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 60, Issue:2

    Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardia

2003
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
    Gastrointestinal endoscopy, 2004, Volume: 59, Issue:1

    Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage;

2004
Are we making efficient use of clopidogrel?
    European heart journal, 2004, Volume: 25, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhib

2004
If there's smoke, is there fire?
    Circulation, 2004, Mar-30, Volume: 109, Issue:12

    Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Endpoint Determination; Hu

2004
Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
    Journal of the American College of Cardiology, 2004, Jul-07, Volume: 44, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coron

2004
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Corona

2004
Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
    The American journal of cardiology, 2004, Oct-01, Volume: 94, Issue:7

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Biomarkers; Blood Vessel Pr

2004
Does clopidogrel increase blood loss following coronary artery bypass surgery?
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:5

    Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critica

2004
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
    European heart journal, 2005, Volume: 26, Issue:6

    Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Coronary Disease

2005
Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats.
    Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2005, Volume: 39, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Dose-Response Relationship,

2005
Technique of left main stenting is dependent on lesion location and distal branch protection.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2005, Volume: 65, Issue:4

    Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Mate

2005
The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome.
    Chest, 2005, Volume: 127, Issue:6

    Topics: Clopidogrel; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Admini

2005
Intense migraines secondary to percutaneous closure of atrial septal defects.
    Journal of interventional cardiology, 2005, Volume: 18, Issue:3

    Topics: Adult; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Female; Follow-Up St

2005
Intracranial bleeding associated with clopidogrel.
    Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Human

2005
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:9

    Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa

2005
Economic effects of extended clopidogrel therapy--a word of caution.
    Journal of the American College of Cardiology, 2005, Oct-04, Volume: 46, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative

2005
Treatment of wide-necked intracranial aneurysms with a self-expanding stent: mid-term results.
    Zentralblatt fur Neurochirurgie, 2005, Volume: 66, Issue:4

    Topics: Aneurysm, Ruptured; Clopidogrel; Follow-Up Studies; Humans; Intracranial Aneurysm; Neurosurgical Pro

2005
Venous thromboembolism and fractured neck of femur.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:5

    Topics: Aged; Aged, 80 and over; Anesthesia; Anticoagulants; Aspirin; Blood Loss, Surgical; Blood Transfusio

2005
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:2

    Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Sel

2006
[Postoperative antithrombotic treatment in diabetic patients].
    Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95 Suppl 1

    Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mell

2006
Saddle embolism after corrective femoral osteotomy: a case report.
    Journal of orthopaedic surgery (Hong Kong), 2006, Volume: 14, Issue:2

    Topics: Arterial Occlusive Diseases; Atrial Fibrillation; Echocardiography, Transesophageal; Embolectomy; Em

2006
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:3

    Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposi

2006
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
    Platelets, 2006, Volume: 17, Issue:5

    Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation;

2006
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Dec-01, Volume: 63, Issue:23

    Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Pa

2006
Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
    Journal of cardiology, 2007, Volume: 49, Issue:6

    Topics: Adolescent; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Humans; Migraine with Aur

2007
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
    Anesthesiology, 2007, Volume: 107, Issue:3

    Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Plat

2007
Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus.
    The Journal of trauma, 2008, Volume: 64, Issue:4

    Topics: Adult; Clopidogrel; Emergency Treatment; Female; Fracture Fixation, Internal; Health Care Surveys; H

2008
[Antithrombotic therapy in operations on extracranial arteries].
    Vestnik khirurgii imeni I. I. Grekova, 2008, Volume: 167, Issue:1

    Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Endarterectomy, Carotid; Female; Fibri

2008
[Comparative action of different platelet anti-aggregants in the postoperative period].
    Cahiers d'anesthesiologie, 1984, Volume: 32, Issue:2

    Topics: Anticoagulants; Dipyridamole; Humans; Papaverine; Parasympatholytics; Platelet Aggregation; Postoper

1984
Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study.
    The Annals of thoracic surgery, 1984, Volume: 37, Issue:5

    Topics: Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Po

1984
Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
    Anesthesia and analgesia, 1983, Volume: 62, Issue:8

    Topics: Aged; Anesthesia, Spinal; Anticoagulants; Female; Hematoma; Humans; Postoperative Complications; Spi

1983
Platelet survival in patients treated with ticlopidine following reconstructive arterial surgery.
    Thrombosis research, 1982, Aug-01, Volume: 27, Issue:3

    Topics: Aged; Aorta; Blood Platelets; Blood Vessel Prosthesis; Cell Survival; Dose-Response Relationship, Dr

1982
Percutaneous transluminal angioplasty for transplant renal artery stenosis.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Angioplasty, Balloon; Female; Heparin; Humans; Kidney Transplantation; Male; Midd

1996
[Treatment with ticlodipine after intracoronary stent implantation].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1996, Jun-10, Volume: 116, Issue:15

    Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet

1996
Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting.
    The American journal of cardiology, 1996, Nov-01, Volume: 78, Issue:9

    Topics: Aged; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Plate

1996
Reduction of thrombotic and hemorrhagic complications after stent implantation.
    American heart journal, 1996, Volume: 132, Issue:6

    Topics: Acute Disease; Aged; Anticoagulants; Coronary Angiography; Coronary Thrombosis; Female; Follow-Up St

1996
Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
    The Canadian journal of cardiology, 1997, Volume: 13, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Ar

1997
Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patients.
    Catheterization and cardiovascular diagnosis, 1997, Volume: 42, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coronary Angiography; Coronary Vessels; Female; Foll

1997
Stenting without ASA?
    Catheterization and cardiovascular diagnosis, 1997, Volume: 42, Issue:4

    Topics: Humans; Incidence; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications

1997
New stent delivery balloon: a technical note.
    Catheterization and cardiovascular diagnosis, 1997, Volume: 42, Issue:4

    Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Hu

1997
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Sangre, 1997, Volume: 42, Issue:5

    Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation

1997
Revascularization after CABG: atherectomy and stenting.
    Hospital practice (1995), 1998, Jan-15, Volume: 33, Issue:1

    Topics: Aftercare; Aged; Algorithms; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Bypass; Co

1998
Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
    The American journal of cardiology, 1998, Jan-15, Volume: 81, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Vessel Prosthesis Implantation; Coro

1998
Micro stent implantation in patients with acute myocardial infarction without anticoagulation: clinical experience with two different antithrombotic protocols.
    Catheterization and cardiovascular diagnosis, 1998, Volume: 44, Issue:2

    Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiograp

1998
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
    Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:4

    Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin;

1998
Coronary stenting in unstable angina: early and late clinical outcomes.
    The Canadian journal of cardiology, 1998, Volume: 14, Issue:9

    Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Disease;

1998
Chronology of use of ticlopidine to prevent stent occlusion.
    Circulation, 1998, Nov-10, Volume: 98, Issue:19

    Topics: Cardiology; History, 20th Century; Humans; Postoperative Complications; Stents; Ticlopidine

1998
[Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin].
    Zeitschrift fur Kardiologie, 1998, Volume: 87, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Coron

1998
Ticlopidine and TTP after coronary stenting.
    JAMA, 1999, Nov-10, Volume: 282, Issue:18

    Topics: Angioplasty, Balloon; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl

1999
Ticlopidine and TTP after coronary stenting.
    JAMA, 1999, Nov-10, Volume: 282, Issue:18

    Topics: Angioplasty, Balloon; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl

1999
Studies published on clopidogrel-aspirin for coronary stent placement.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Jan-15, Volume: 57, Issue:2

    Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Combinations; Humans; Platelet Agg

2000
Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
    The Canadian journal of cardiology, 2000, Volume: 16, Issue:4

    Topics: Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Female; Fibrinolytic Agents; Follow-Up

2000
Acute renal failure and thrombocytopenia after ticlopidine--not necessarily thrombotic thrombocytopenic purpura.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:7

    Topics: Acute Kidney Injury; Aged; Coronary Disease; Diagnosis, Differential; Embolism, Cholesterol; Female;

2000
Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report.
    Angiology, 2000, Volume: 51, Issue:7

    Topics: Agranulocytosis; Coronary Disease; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Age

2000
Clopidogrel instead of ticlopidine after coronary stent placement: is the switch justified?
    American heart journal, 2000, Volume: 140, Issue:3

    Topics: Clopidogrel; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Complic

2000
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    American heart journal, 2000, Volume: 140, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coron

2000
Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    International journal of cardiology, 2001, Volume: 78, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Cilos

2001
[Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:5

    Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl

2001
[Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:7

    Topics: Clinical Trials as Topic; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative C

2001
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century.
    The Journal of invasive cardiology, 2001, Volume: 13, Issue:12

    Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Co

2001
Treatment of acute coronary syndromes.
    The New England journal of medicine, 2002, Jan-17, Volume: 346, Issue:3

    Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Hemorrhage;

2002
OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey.
    The heart surgery forum, 2001, Volume: 4, Issue:4

    Topics: Anticoagulants; Aspirin; Canada; Cardiology; Clopidogrel; Combined Modality Therapy; Coronary Artery

2001
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6

    Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia;

2001
[Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
    Kokyu to junkan. Respiration & circulation, 1989, Volume: 37, Issue:1

    Topics: Adult; Aged; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggre

1989
Clinical application of a new in vitro bleeding time device on surgical patients.
    The Japanese journal of surgery, 1988, Volume: 18, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aspirin; Bleeding Time; Epoprostenol; Hemorrhage; Hemostasis; H

1988
[Inhibitory effect of ticlopidine on platelet aggregation in open heart surgery].
    Kyobu geka. The Japanese journal of thoracic surgery, 1987, Volume: 40, Issue:6

    Topics: Administration, Oral; Barbiturates; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart Valve P

1987
[Abnormalities of blood coagulation and effect of anticoagulant therapy in postoperative patients with lung cancer].
    Nihon Geka Gakkai zasshi, 1986, Volume: 87, Issue:6

    Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Blood Coagulation Disorders; Female; Humans; Lung

1986
[Efficacy and mechanisms of action of ticlopidine: a drug useful in maintaining aortocoronary bypass patency].
    Minerva cardioangiologica, 1987, Volume: 35, Issue:3

    Topics: beta-Thromboglobulin; Coronary Artery Bypass; Humans; Middle Aged; Postoperative Complications; Thro

1987
[Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1988, Volume: 36, Issue:11

    Topics: Blood Platelets; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet A

1988
[Current topics of anticoagulant therapy and antiplatelet therapy after cardiac valve replacement].
    Kyobu geka. The Japanese journal of thoracic surgery, 1988, Volume: 41, Issue:8

    Topics: Adolescent; Adult; Aspirin; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Ag

1988
[Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1985, Volume: 33, Issue:1

    Topics: Adult; Anticoagulants; Blood Coagulation; Dipyridamole; Female; Heart Valve Diseases; Heart Valve Pr

1985
Ticlopidine as a hemorrhagic risk factor in coronary surgery.
    Drug intelligence & clinical pharmacy, 1985, Volume: 19, Issue:9

    Topics: Adult; Coronary Disease; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Count; Pos

1985